-
1
-
-
79952284127
-
Hallmarks of cancer: The next generation
-
1:CAS:528:DC%2BC3MXjsFeqtrk%3D 21376230
-
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-74.
-
(2011)
Cell
, vol.144
, Issue.5
, pp. 646-674
-
-
Hanahan, D.1
Weinberg, R.A.2
-
2
-
-
84990989710
-
Epigenetics of hematopoiesis and hematological malignancies
-
1:CAS:528:DC%2BC2sXhtlKqtr4%3D 27798847 5066610
-
Hu D, Shilatifard A. Epigenetics of hematopoiesis and hematological malignancies. Genes Dev. 2016;30(18):2021-41.
-
(2016)
Genes Dev
, vol.30
, Issue.18
, pp. 2021-2041
-
-
Hu, D.1
Shilatifard, A.2
-
3
-
-
84890406729
-
Is cancer a metabolic disease?
-
24139946 3873478
-
Coller HA. Is cancer a metabolic disease? Am J Pathol. 2014;184(1):4-17.
-
(2014)
Am J Pathol
, vol.184
, Issue.1
, pp. 4-17
-
-
Coller, H.A.1
-
4
-
-
84858604270
-
Metabolic reprogramming: A cancer hallmark even warburg did not anticipate
-
1:CAS:528:DC%2BC38Xkt1ylsbc%3D 22439925 3311998
-
Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell. 2012;21(3):297-308.
-
(2012)
Cancer Cell
, vol.21
, Issue.3
, pp. 297-308
-
-
Ward, P.S.1
Thompson, C.B.2
-
5
-
-
84919644742
-
The amino acid transporter SLC6A14 in cancer and its potential use in chemotherapy
-
Bhutia YD, Babu E, Prasad PD, Ganapathy V. The amino acid transporter SLC6A14 in cancer and its potential use in chemotherapy. Asian J Pharm Sci. 2014;9(6):293-303.
-
(2014)
Asian J Pharm Sci
, vol.9
, Issue.6
, pp. 293-303
-
-
Bhutia, Y.D.1
Babu, E.2
Prasad, P.D.3
Ganapathy, V.4
-
6
-
-
12444279265
-
On the origin of cancer cells
-
1:STN:280:DyaG28%2FltV2ktQ%3D%3D 13298683
-
Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309-14.
-
(1956)
Science
, vol.123
, Issue.3191
, pp. 309-314
-
-
Warburg, O.1
-
7
-
-
0027145124
-
Glutamine and cancer
-
1:STN:280:DyaK2c%2FnvFCmsA%3D%3D 8257221 1243066
-
Souba WW. Glutamine and cancer. Ann Surg. 1993;218(6):715-28.
-
(1993)
Ann Surg
, vol.218
, Issue.6
, pp. 715-728
-
-
Souba, W.W.1
-
8
-
-
77955281020
-
Glutamine addiction: A new therapeutic target in cancer
-
1:CAS:528:DC%2BC3cXpvFKqs7s%3D 20570523 2917518
-
Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci. 2010;35(8):427-33.
-
(2010)
Trends Biochem Sci
, vol.35
, Issue.8
, pp. 427-433
-
-
Wise, D.R.1
Thompson, C.B.2
-
9
-
-
34347402459
-
Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells
-
1:CAS:528:DC%2BD2sXnsVajurY%3D 17606868 2064426
-
Yuneva M, Zamboni N, Oefner P, Sachidanandam R, Lazebnik Y. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol. 2007;178(1):93-105.
-
(2007)
J Cell Biol
, vol.178
, Issue.1
, pp. 93-105
-
-
Yuneva, M.1
Zamboni, N.2
Oefner, P.3
Sachidanandam, R.4
Lazebnik, Y.5
-
10
-
-
0018704340
-
Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: A report from Childrens Cancer Study Group
-
1:STN:280:DyaL3c%2FgtFGquw%3D%3D 383278
-
Ertel IJ, Nesbit ME, Hammond D, Weiner J, Sather H. Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: a report from Childrens Cancer Study Group. Cancer Res. 1979;39(10):3893-6.
-
(1979)
Cancer Res
, vol.39
, Issue.10
, pp. 3893-3896
-
-
Ertel, I.J.1
Nesbit, M.E.2
Hammond, D.3
Weiner, J.4
Sather, H.5
-
11
-
-
78651010566
-
Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid
-
1:CAS:528:DyaH1cXjt1Chtg%3D%3D 18860765
-
Farber S, Diamond LK. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. N Engl J Med. 1948;238(23):787-93.
-
(1948)
N Engl J Med
, vol.238
, Issue.23
, pp. 787-793
-
-
Farber, S.1
Diamond, L.K.2
-
12
-
-
80052242132
-
Targeting cancer metabolism: A therapeutic window opens
-
1:CAS:528:DC%2BC3MXhtFSltb3J 21878982
-
Vander Heiden MG. Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov. 2011;10(9):671-84.
-
(2011)
Nat Rev Drug Discov
, vol.10
, Issue.9
, pp. 671-684
-
-
Vander Heiden, M.G.1
-
13
-
-
0036792124
-
Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo
-
1:CAS:528:DC%2BD38Xnsl2ls7s%3D 12359751
-
Ensor CM, Holtsberg FW, Bomalaski JS, Clark MA. Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo. Cancer Res. 2002;62(19):5443-50.
-
(2002)
Cancer Res
, vol.62
, Issue.19
, pp. 5443-5450
-
-
Ensor, C.M.1
Holtsberg, F.W.2
Bomalaski, J.S.3
Clark, M.A.4
-
14
-
-
4744359216
-
Arginine and cancer
-
1:CAS:528:DC%2BD2cXosVOjsL4%3D 15465796 discussion 53S
-
Lind DS. Arginine and cancer. J Nutr. 2004;134(10 Suppl):2837S-41S. discussion 53S.
-
(2004)
J Nutr
, vol.134
, Issue.10
, pp. 41S-2837S
-
-
Lind, D.S.1
-
15
-
-
66249108601
-
Understanding the Warburg effect: The metabolic requirements of cell proliferation
-
1:CAS:528:DC%2BD1MXmtVKlsbg%3D 19460998 2849637
-
Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029-33.
-
(2009)
Science
, vol.324
, Issue.5930
, pp. 1029-1033
-
-
Vander Heiden, M.G.1
Cantley, L.C.2
Thompson, C.B.3
-
16
-
-
23944431858
-
Nutritional control of gene expression: How mammalian cells respond to amino acid limitation
-
1:CAS:528:DC%2BD2MXpvF2msbk%3D 16011459 3600373
-
Kilberg MS, Pan YX, Chen H, Leung-Pineda V. Nutritional control of gene expression: how mammalian cells respond to amino acid limitation. Annu Rev Nutr. 2005;25:59-85.
-
(2005)
Annu Rev Nutr
, vol.25
, pp. 59-85
-
-
Kilberg, M.S.1
Pan, Y.X.2
Chen, H.3
Leung-Pineda, V.4
-
17
-
-
84904678420
-
The general amino acid control pathway regulates mTOR and autophagy during serum/glutamine starvation
-
1:CAS:528:DC%2BC2cXht1emsLjP 25049270 4107793
-
Chen R, Zou Y, Mao D, Sun D, Gao G, Shi J, Liu X, Zhu C, Yang M, Ye W, et al. The general amino acid control pathway regulates mTOR and autophagy during serum/glutamine starvation. J Cell Biol. 2014;206(2):173-82.
-
(2014)
J Cell Biol
, vol.206
, Issue.2
, pp. 173-182
-
-
Chen, R.1
Zou, Y.2
Mao, D.3
Sun, D.4
Gao, G.5
Shi, J.6
Liu, X.7
Zhu, C.8
Yang, M.9
Ye, W.10
-
18
-
-
24744441497
-
Autophagy is required for maintenance of amino acid levels and protein synthesis under nitrogen starvation
-
1:CAS:528:DC%2BD2MXpslaqu7c%3D 16027116
-
Onodera J, Ohsumi Y. Autophagy is required for maintenance of amino acid levels and protein synthesis under nitrogen starvation. J Biol Chem. 2005;280(36):31582-6.
-
(2005)
J Biol Chem
, vol.280
, Issue.36
, pp. 31582-31586
-
-
Onodera, J.1
Ohsumi, Y.2
-
19
-
-
84881079572
-
Amino acid deprivation promotes tumor angiogenesis through the GCN2/ATF4 pathway
-
23908598 3730049
-
Wang Y, Ning Y, Alam GN, Jankowski BM, Dong Z, Nor JE, Polverini PJ. Amino acid deprivation promotes tumor angiogenesis through the GCN2/ATF4 pathway. Neoplasia. 2013;15(8):989-97.
-
(2013)
Neoplasia
, vol.15
, Issue.8
, pp. 989-997
-
-
Wang, Y.1
Ning, Y.2
Alam, G.N.3
Jankowski, B.M.4
Dong, Z.5
Nor, J.E.6
Polverini, P.J.7
-
20
-
-
84960426299
-
Recent developments in l-asparaginase discovery and its potential as anticancer agent
-
25630663
-
Shrivastava A, Khan AA, Khurshid M, Kalam MA, Jain SK, Singhal PK. Recent developments in l-asparaginase discovery and its potential as anticancer agent. Crit Rev Oncol Hematol. 2016;100:1-10.
-
(2016)
Crit Rev Oncol Hematol
, vol.100
, pp. 1-10
-
-
Shrivastava, A.1
Khan, A.A.2
Khurshid, M.3
Kalam, M.A.4
Jain, S.K.5
Singhal, P.K.6
-
21
-
-
24744445331
-
Amino acid deprivation induces both apoptosis and autophagy in murine C2C12 muscle cells
-
1:CAS:528:DC%2BD2MXpvFOkt7c%3D 16158257
-
Martinet W, De Meyer GR, Herman AG, Kockx MM. Amino acid deprivation induces both apoptosis and autophagy in murine C2C12 muscle cells. Biotechnol Lett. 2005;27(16):1157-63.
-
(2005)
Biotechnol Lett
, vol.27
, Issue.16
, pp. 1157-1163
-
-
Martinet, W.1
De Meyer, G.R.2
Herman, A.G.3
Kockx, M.M.4
-
22
-
-
33747431574
-
Amino acid starvation induced autophagic cell death in PC-12 cells: Evidence for activation of caspase-3 but not calpain-1
-
1:CAS:528:DC%2BD28Xot12jtLg%3D 16703260
-
Sadasivan S, Waghray A, Larner SF, Dunn Jr WA, Hayes RL, Wang KK. Amino acid starvation induced autophagic cell death in PC-12 cells: evidence for activation of caspase-3 but not calpain-1. Apoptosis. 2006;11(9):1573-82.
-
(2006)
Apoptosis
, vol.11
, Issue.9
, pp. 1573-1582
-
-
Sadasivan, S.1
Waghray, A.2
Larner, S.F.3
Dunn, W.A.4
Hayes, R.L.5
Wang, K.K.6
-
23
-
-
27644514227
-
Another way to die: Autophagic programmed cell death
-
1:CAS:528:DC%2BD2MXhtFCjt7%2FL 16247500
-
Tsujimoto Y, Shimizu S. Another way to die: autophagic programmed cell death. Cell Death Differ. 2005;12 Suppl 2:1528-34.
-
(2005)
Cell Death Differ
, vol.12
, pp. 1528-1534
-
-
Tsujimoto, Y.1
Shimizu, S.2
-
24
-
-
84982993825
-
From Krebs to clinic: Glutamine metabolism to cancer therapy
-
1:CAS:528:DC%2BC28Xht12jurbI 27492215 5484415
-
Altman BJ, Stine ZE, Dang CV. From Krebs to clinic: glutamine metabolism to cancer therapy. Nat Rev Cancer. 2016;16(10):619-34.
-
(2016)
Nat Rev Cancer
, vol.16
, Issue.10
, pp. 619-634
-
-
Altman, B.J.1
Stine, Z.E.2
Dang, C.V.3
-
25
-
-
84865168175
-
Pediatric acute lymphoblastic leukemia: Where are we going and how do we get there?
-
1:CAS:528:DC%2BC38Xht1WjsrrN 22730540 3418713
-
Pui CH, Mullighan CG, Evans WE, Relling MV. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood. 2012;120(6):1165-74.
-
(2012)
Blood
, vol.120
, Issue.6
, pp. 1165-1174
-
-
Pui, C.H.1
Mullighan, C.G.2
Evans, W.E.3
Relling, M.V.4
-
26
-
-
77957245576
-
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients
-
1:CAS:528:DC%2BC3cXht1WlsrfM 20808309 2965867
-
Yang TS, Lu SN, Chao Y, Sheen IS, Lin CC, Wang TE, Chen SC, Wang JH, Liao LY, Thomson JA, et al. A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients. Br J Cancer. 2010;103(7):954-60.
-
(2010)
Br J Cancer
, vol.103
, Issue.7
, pp. 954-960
-
-
Yang, T.S.1
Lu, S.N.2
Chao, Y.3
Sheen, I.S.4
Lin, C.C.5
Wang, T.E.6
Chen, S.C.7
Wang, J.H.8
Liao, L.Y.9
Thomson, J.A.10
-
27
-
-
84873814665
-
A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma
-
1:CAS:528:DC%2BC3sXhs1Ohurw%3D 22426640
-
Yau T, Cheng PN, Chan P, Chan W, Chen L, Yuen J, Pang R, Fan ST, Poon RT. A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma. Invest New Drugs. 2013;31(1):99-107.
-
(2013)
Invest New Drugs
, vol.31
, Issue.1
, pp. 99-107
-
-
Yau, T.1
Cheng, P.N.2
Chan, P.3
Chan, W.4
Chen, L.5
Yuen, J.6
Pang, R.7
Fan, S.T.8
Poon, R.T.9
-
28
-
-
84864040884
-
Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells
-
1:CAS:528:DC%2BC38Xhtl2kurzM 22750268
-
Chen JQ, Russo J. Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. Biochim Biophys Acta. 2012;1826(2):370-84.
-
(2012)
Biochim Biophys Acta
, vol.1826
, Issue.2
, pp. 370-384
-
-
Chen, J.Q.1
Russo, J.2
-
29
-
-
84869009687
-
How cancer metabolism is tuned for proliferation and vulnerable to disruption
-
1:CAS:528:DC%2BC38Xhs1Ogt77F 23151579
-
Schulze A, Harris AL. How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature. 2012;491(7424):364-73.
-
(2012)
Nature
, vol.491
, Issue.7424
, pp. 364-373
-
-
Schulze, A.1
Harris, A.L.2
-
31
-
-
57749088701
-
Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
-
1:CAS:528:DC%2BD1cXhsV2rtL%2FK 19033189 2596212
-
Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK, Nissim I, Daikhin E, Yudkoff M, McMahon SB, et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci U S A. 2008;105(48):18782-7.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, Issue.48
, pp. 18782-18787
-
-
Wise, D.R.1
DeBerardinis, R.J.2
Mancuso, A.3
Sayed, N.4
Zhang, X.Y.5
Pfeiffer, H.K.6
Nissim, I.7
Daikhin, E.8
Yudkoff, M.9
McMahon, S.B.10
-
32
-
-
70350217425
-
Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling
-
1:CAS:528:DC%2BD1MXht1ynurbK 19826036 2764330
-
Yang C, Sudderth J, Dang T, Bachoo RM, McDonald JG, DeBerardinis RJ. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. Cancer Res. 2009;69(20):7986-93.
-
(2009)
Cancer Res
, vol.69
, Issue.20
, pp. 7986-7993
-
-
Yang, C.1
Sudderth, J.2
Dang, T.3
Bachoo, R.M.4
McDonald, J.G.5
DeBerardinis, R.J.6
-
33
-
-
84883497454
-
Glutamine and cancer: Cell biology, physiology, and clinical opportunities
-
1:CAS:528:DC%2BC3sXhsVenu7bL 23999442 3754270
-
Hensley CT, Wasti AT, DeBerardinis RJ. Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest. 2013;123(9):3678-84.
-
(2013)
J Clin Invest
, vol.123
, Issue.9
, pp. 3678-3684
-
-
Hensley, C.T.1
Wasti, A.T.2
DeBerardinis, R.J.3
-
34
-
-
77956516647
-
Cancer metabolism: Is glutamine sweeter than glucose?
-
1:CAS:528:DC%2BC3cXhtFGht7nF 20832746 2952340
-
Lu W, Pelicano H, Huang P. Cancer metabolism: is glutamine sweeter than glucose? Cancer Cell. 2010;18(3):199-200.
-
(2010)
Cancer Cell
, vol.18
, Issue.3
, pp. 199-200
-
-
Lu, W.1
Pelicano, H.2
Huang, P.3
-
35
-
-
84928408102
-
Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma
-
25844758 4480704
-
Yu D, Shi X, Meng G, Chen J, Yan C, Jiang Y, Wei J, Ding Y. Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma. Oncotarget. 2015;6(10):7619-31.
-
(2015)
Oncotarget
, vol.6
, Issue.10
, pp. 7619-7631
-
-
Yu, D.1
Shi, X.2
Meng, G.3
Chen, J.4
Yan, C.5
Jiang, Y.6
Wei, J.7
Ding, Y.8
-
36
-
-
84899512958
-
Expression of glutaminase is upregulated in colorectal cancer and of clinical significance
-
24696726 3971313
-
Huang F, Zhang Q, Ma H, Lv Q, Zhang T. Expression of glutaminase is upregulated in colorectal cancer and of clinical significance. Int J Clin Exp Pathol. 2014;7(3):1093-100.
-
(2014)
Int J Clin Exp Pathol
, vol.7
, Issue.3
, pp. 1093-1100
-
-
Huang, F.1
Zhang, Q.2
Ma, H.3
Lv, Q.4
Zhang, T.5
-
37
-
-
84908360969
-
Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts
-
1:CAS:528:DC%2BC2cXht1GksL3M 25072259 4453854
-
Chiu M, Tardito S, Pillozzi S, Arcangeli A, Armento A, Uggeri J, Missale G, Bianchi MG, Barilli A, Dall'Asta V, et al. Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts. Br J Cancer. 2014;111(6):1159-67.
-
(2014)
Br J Cancer
, vol.111
, Issue.6
, pp. 1159-1167
-
-
Chiu, M.1
Tardito, S.2
Pillozzi, S.3
Arcangeli, A.4
Armento, A.5
Uggeri, J.6
Missale, G.7
Bianchi, M.G.8
Barilli, A.9
Dall'Asta, V.10
-
38
-
-
0018123526
-
Mechanism of sensitivity of cultured pancreatic carcinoma to asparaginase
-
1:CAS:528:DyaE1MXpslCjtQ%3D%3D 363626
-
Wu MC, Arimura GK, Yunis AA. Mechanism of sensitivity of cultured pancreatic carcinoma to asparaginase. Int J Cancer. 1978;22(6):728-33.
-
(1978)
Int J Cancer
, vol.22
, Issue.6
, pp. 728-733
-
-
Wu, M.C.1
Arimura, G.K.2
Yunis, A.A.3
-
39
-
-
84873363313
-
SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival
-
1:CAS:528:DC%2BC3sXitVOht7s%3D 23213057
-
Hassanein M, Hoeksema MD, Shiota M, Qian J, Harris BK, Chen H, Clark JE, Alborn WE, Eisenberg R, Massion PP. SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival. Clin Cancer Res. 2013;19(3):560-70.
-
(2013)
Clin Cancer Res
, vol.19
, Issue.3
, pp. 560-570
-
-
Hassanein, M.1
Hoeksema, M.D.2
Shiota, M.3
Qian, J.4
Harris, B.K.5
Chen, H.6
Clark, J.E.7
Alborn, W.E.8
Eisenberg, R.9
Massion, P.P.10
-
40
-
-
84906270661
-
Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells
-
25026281 4171615
-
Lee YZ, Yang CW, Chang HY, Hsu HY, Chen IS, Chang HS, Lee CH, Lee JC, Kumar CR, Qiu YQ, et al. Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells. Oncotarget. 2014;5(15):6087-101.
-
(2014)
Oncotarget
, vol.5
, Issue.15
, pp. 6087-6101
-
-
Lee, Y.Z.1
Yang, C.W.2
Chang, H.Y.3
Hsu, H.Y.4
Chen, I.S.5
Chang, H.S.6
Lee, C.H.7
Lee, J.C.8
Kumar, C.R.9
Qiu, Y.Q.10
-
41
-
-
84904645105
-
Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer
-
1:CAS:528:DC%2BC2cXls1Gjurg%3D 24523301
-
Gross MI, Demo SD, Dennison JB, Chen L, Chernov-Rogan T, Goyal B, Janes JR, Laidig GJ, Lewis ER, Li J, et al. Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol Cancer Ther. 2014;13(4):890-901.
-
(2014)
Mol Cancer Ther
, vol.13
, Issue.4
, pp. 890-901
-
-
Gross, M.I.1
Demo, S.D.2
Dennison, J.B.3
Chen, L.4
Chernov-Rogan, T.5
Goyal, B.6
Janes, J.R.7
Laidig, G.J.8
Lewis, E.R.9
Li, J.10
-
42
-
-
35448987680
-
Complement susceptibility in glutamine deprived breast cancer cells
-
Ellison BS, Zanin MK, Boackle RJ. Complement susceptibility in glutamine deprived breast cancer cells. Cell Div. 2007;2:20. doi: 10.1186/1747-1028-2-20.
-
(2007)
Cell Div
, vol.2
, pp. 20
-
-
Ellison, B.S.1
Zanin, M.K.2
Boackle, R.J.3
-
43
-
-
79951483189
-
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
-
1:CAS:528:DC%2BC3MXisFKqs7s%3D 21123825
-
Jaccard A, Gachard N, Marin B, Rogez S, Audrain M, Suarez F, Tilly H, Morschhauser F, Thieblemont C, Ysebaert L, et al. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. Blood. 2011;117(6):1834-9.
-
(2011)
Blood
, vol.117
, Issue.6
, pp. 1834-1839
-
-
Jaccard, A.1
Gachard, N.2
Marin, B.3
Rogez, S.4
Audrain, M.5
Suarez, F.6
Tilly, H.7
Morschhauser, F.8
Thieblemont, C.9
Ysebaert, L.10
-
44
-
-
84888231872
-
Asparaginase unveils glutamine-addicted AML
-
1:CAS:528:DC%2BC3sXhvVeiu7fE 24235130
-
Samudio I, Konopleva M. Asparaginase unveils glutamine-addicted AML. Blood. 2013;122(20):3398-400.
-
(2013)
Blood
, vol.122
, Issue.20
, pp. 3398-3400
-
-
Samudio, I.1
Konopleva, M.2
-
45
-
-
84865679567
-
Asparaginases: Biochemical pharmacology and modes of drug resistance
-
1:CAS:528:DC%2BC38Xht1aks7%2FL 22753699
-
Avramis VI. Asparaginases: biochemical pharmacology and modes of drug resistance. Anticancer Res. 2012;32(7):2423-37.
-
(2012)
Anticancer Res
, vol.32
, Issue.7
, pp. 2423-2437
-
-
Avramis, V.I.1
-
46
-
-
0019293446
-
Phase II study of L-asparaginase in the treatment of pancreatic carcinoma
-
1:STN:280:DyaL3M7jsFKmtg%3D%3D 7471124
-
Lessner HE, Valenstein S, Kaplan R, DeSimone P, Yunis A. Phase II study of L-asparaginase in the treatment of pancreatic carcinoma. Cancer Treat Rep. 1980;64(12):1359-61.
-
(1980)
Cancer Treat Rep
, vol.64
, Issue.12
, pp. 1359-1361
-
-
Lessner, H.E.1
Valenstein, S.2
Kaplan, R.3
DeSimone, P.4
Yunis, A.5
-
47
-
-
84902196856
-
The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells
-
1:CAS:528:DC%2BC2cXps12qtLg%3D 24659632 4047499
-
Chan WK, Lorenzi PL, Anishkin A, Purwaha P, Rogers DM, Sukharev S, Rempe SB, Weinstein JN. The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells. Blood. 2014;123(23):3596-606.
-
(2014)
Blood
, vol.123
, Issue.23
, pp. 3596-3606
-
-
Chan, W.K.1
Lorenzi, P.L.2
Anishkin, A.3
Purwaha, P.4
Rogers, D.M.5
Sukharev, S.6
Rempe, S.B.7
Weinstein, J.N.8
-
48
-
-
34547838476
-
The inhibition of glutamine synthetase sensitizes human sarcoma cells to L-asparaginase
-
1:CAS:528:DC%2BD2sXovFSrsbw%3D 17256128
-
Tardito S, Uggeri J, Bozzetti C, Bianchi MG, Rotoli BM, Franchi-Gazzola R, Gazzola GC, Gatti R, Bussolati O. The inhibition of glutamine synthetase sensitizes human sarcoma cells to L-asparaginase. Cancer Chemother Pharmacol. 2007;60(5):751-8.
-
(2007)
Cancer Chemother Pharmacol
, vol.60
, Issue.5
, pp. 751-758
-
-
Tardito, S.1
Uggeri, J.2
Bozzetti, C.3
Bianchi, M.G.4
Rotoli, B.M.5
Franchi-Gazzola, R.6
Gazzola, G.C.7
Gatti, R.8
Bussolati, O.9
-
49
-
-
84924261564
-
The GLU that holds cancer together: Targeting GLUtamine transporters in breast cancer
-
1:CAS:528:DC%2BC2MXktFOgtLg%3D 25759015
-
Moses MA, Neckers L. The GLU that holds cancer together: targeting GLUtamine transporters in breast cancer. Cancer Cell. 2015;27(3):317-9.
-
(2015)
Cancer Cell
, vol.27
, Issue.3
, pp. 317-319
-
-
Moses, M.A.1
Neckers, L.2
-
50
-
-
84946045408
-
Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening
-
26444490 4596572
-
Colas C, Grewer C, Otte NJ, Gameiro A, Albers T, Singh K, Shere H, Bonomi M, Holst J, Schlessinger A. Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening. PLoS Comput Biol. 2015;11(10):e1004477.
-
(2015)
PLoS Comput Biol
, vol.11
, Issue.10
, pp. e1004477
-
-
Colas, C.1
Grewer, C.2
Otte, N.J.3
Gameiro, A.4
Albers, T.5
Singh, K.6
Shere, H.7
Bonomi, M.8
Holst, J.9
Schlessinger, A.10
-
51
-
-
3242689793
-
New inhibitors for the neutral amino acid transporter ASCT2 reveal its Na + -dependent anion leak
-
1:CAS:528:DC%2BD2cXlslejtLg%3D 15107471 1665628
-
Grewer C, Grabsch E. New inhibitors for the neutral amino acid transporter ASCT2 reveal its Na + -dependent anion leak. J Physiol. 2004;557(Pt 3):747-59.
-
(2004)
J Physiol
, vol.557
, pp. 747-759
-
-
Grewer, C.1
Grabsch, E.2
-
52
-
-
84930482603
-
Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development
-
1:CAS:528:DC%2BC2MXpslOksb8%3D 25693838 4973854
-
Wang Q, Hardie RA, Hoy AJ, van Geldermalsen M, Gao D, Fazli L, Sadowski MC, Balaban S, Schreuder M, Nagarajah R, et al. Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development. J Pathol. 2015;236(3):278-89.
-
(2015)
J Pathol
, vol.236
, Issue.3
, pp. 278-289
-
-
Wang, Q.1
Hardie, R.A.2
Hoy, A.J.3
Van Geldermalsen, M.4
Gao, D.5
Fazli, L.6
Sadowski, M.C.7
Balaban, S.8
Schreuder, M.9
Nagarajah, R.10
-
53
-
-
84899089555
-
Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutations
-
1:CAS:528:DC%2BC2cXmvV2gurk%3D 24333121
-
Emadi A, Jun SA, Tsukamoto T, Fathi AT, Minden MD, Dang CV. Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutations. Exp Hematol. 2014;42(4):247-51.
-
(2014)
Exp Hematol
, vol.42
, Issue.4
, pp. 247-251
-
-
Emadi, A.1
Jun, S.A.2
Tsukamoto, T.3
Fathi, A.T.4
Minden, M.D.5
Dang, C.V.6
-
54
-
-
85018392260
-
A novel glutaminase inhibitor-968 inhibits the migration and proliferation of non-small cell lung cancer cells by targeting EGFR/ERK signaling pathway
-
28039459
-
Han T, Guo M, Zhang T, Gan M, Xie C, Wang JB. A novel glutaminase inhibitor-968 inhibits the migration and proliferation of non-small cell lung cancer cells by targeting EGFR/ERK signaling pathway. Oncotarget. 2017;8(17):28063-73.
-
(2017)
Oncotarget
, vol.8
, Issue.17
, pp. 28063-28073
-
-
Han, T.1
Guo, M.2
Zhang, T.3
Gan, M.4
Xie, C.5
Wang, J.B.6
-
55
-
-
78549283855
-
Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1
-
1:CAS:528:DC%2BC3cXhsVWmsL3N 21045145 3058858
-
Seltzer MJ, Bennett BD, Joshi AD, Gao P, Thomas AG, Ferraris DV, Tsukamoto T, Rojas CJ, Slusher BS, Rabinowitz JD, et al. Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. Cancer Res. 2010;70(22):8981-7.
-
(2010)
Cancer Res
, vol.70
, Issue.22
, pp. 8981-8987
-
-
Seltzer, M.J.1
Bennett, B.D.2
Joshi, A.D.3
Gao, P.4
Thomas, A.G.5
Ferraris, D.V.6
Tsukamoto, T.7
Rojas, C.J.8
Slusher, B.S.9
Rabinowitz, J.D.10
-
56
-
-
84994756840
-
The Glutaminase-1 Inhibitor 968 Enhances Dihydroartemisinin-Mediated Antitumor Efficacy in Hepatocellular Carcinoma Cells
-
27835669 5105986
-
Wang D, Meng G, Zheng M, Zhang Y, Chen A, Wu J, Wei J. The Glutaminase-1 Inhibitor 968 Enhances Dihydroartemisinin-Mediated Antitumor Efficacy in Hepatocellular Carcinoma Cells. PLoS One. 2016;11(11):e0166423.
-
(2016)
PLoS One
, vol.11
, Issue.11
, pp. e0166423
-
-
Wang, D.1
Meng, G.2
Zheng, M.3
Zhang, Y.4
Chen, A.5
Wu, J.6
Wei, J.7
-
57
-
-
77956497712
-
Targeting mitochondrial glutaminase activity inhibits oncogenic transformation
-
1:CAS:528:DC%2BC3cXhtFGht7bO 20832749 3078749
-
Wang JB, Erickson JW, Fuji R, Ramachandran S, Gao P, Dinavahi R, Wilson KF, Ambrosio AL, Dias SM, Dang CV, et al. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell. 2010;18(3):207-19.
-
(2010)
Cancer Cell
, vol.18
, Issue.3
, pp. 207-219
-
-
Wang, J.B.1
Erickson, J.W.2
Fuji, R.3
Ramachandran, S.4
Gao, P.5
Dinavahi, R.6
Wilson, K.F.7
Ambrosio, A.L.8
Dias, S.M.9
Dang, C.V.10
-
58
-
-
84930392977
-
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis
-
25915584 4497742
-
Xiang Y, Stine ZE, Xia J, Lu Y, O'Connor RS, Altman BJ, Hsieh AL, Gouw AM, Thomas AG, Gao P, et al. Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis. J Clin Invest. 2015;125(6):2293-306.
-
(2015)
J Clin Invest
, vol.125
, Issue.6
, pp. 2293-2306
-
-
Xiang, Y.1
Stine, Z.E.2
Xia, J.3
Lu, Y.4
O'Connor, R.S.5
Altman, B.J.6
Hsieh, A.L.7
Gouw, A.M.8
Thomas, A.G.9
Gao, P.10
-
59
-
-
84994164358
-
Glutaminase inhibitor compound 968 inhibits cell proliferation and sensitizes paclitaxel in ovarian cancer
-
27830010 5095319
-
Yuan L, Sheng X, Clark LH, Zhang L, Guo H, Jones HM, Willson AK, Gehrig PA, Zhou C, Bae-Jump VL. Glutaminase inhibitor compound 968 inhibits cell proliferation and sensitizes paclitaxel in ovarian cancer. Am J Transl Res. 2016;8(10):4265-77.
-
(2016)
Am J Transl Res
, vol.8
, Issue.10
, pp. 4265-4277
-
-
Yuan, L.1
Sheng, X.2
Clark, L.H.3
Zhang, L.4
Guo, H.5
Jones, H.M.6
Willson, A.K.7
Gehrig, P.A.8
Zhou, C.9
Bae-Jump, V.L.10
-
60
-
-
84884548852
-
Therapeutic strategies impacting cancer cell glutamine metabolism
-
1:CAS:528:DC%2BC3sXhsVOgsb7P 24047273 4154374
-
Lukey MJ, Wilson KF, Cerione RA. Therapeutic strategies impacting cancer cell glutamine metabolism. Future Med Chem. 2013;5(14):1685-700.
-
(2013)
Future Med Chem
, vol.5
, Issue.14
, pp. 1685-1700
-
-
Lukey, M.J.1
Wilson, K.F.2
Cerione, R.A.3
-
61
-
-
84986216573
-
Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer
-
1:CAS:528:DC%2BC28Xhtl2ktbbM 27559084 5018752
-
Elgogary A, Xu Q, Poore B, Alt J, Zimmermann SC, Zhao L, Fu J, Chen B, Xia S, Liu Y, et al. Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer. Proc Natl Acad Sci U S A. 2016;113(36):E5328-36.
-
(2016)
Proc Natl Acad Sci U S A
, vol.113
, Issue.36
, pp. E5328-E5336
-
-
Elgogary, A.1
Xu, Q.2
Poore, B.3
Alt, J.4
Zimmermann, S.C.5
Zhao, L.6
Fu, J.7
Chen, B.8
Xia, S.9
Liu, Y.10
-
62
-
-
84942149730
-
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition
-
1:CAS:528:DC%2BC28Xht1WisLs%3D 26186940 4608389
-
Jacque N, Ronchetti AM, Larrue C, Meunier G, Birsen R, Willems L, Saland E, Decroocq J, Maciel TT, Lambert M, et al. Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition. Blood. 2015;126(11):1346-56.
-
(2015)
Blood
, vol.126
, Issue.11
, pp. 1346-1356
-
-
Jacque, N.1
Ronchetti, A.M.2
Larrue, C.3
Meunier, G.4
Birsen, R.5
Willems, L.6
Saland, E.7
Decroocq, J.8
Maciel, T.T.9
Lambert, M.10
-
63
-
-
85011431464
-
Phase 1 Study of CB-839, a First-in-Class. Orally Administered Small Molecule Inhibitor of Glutaminase in Patients with Relapsed/Refractory Leukemia
-
Wang ESFO, Orford KW, Bennett MK, Flinn IW, Maris MB, Konopleva MY. Phase 1 Study of CB-839, a First-in-Class. Orally Administered Small Molecule Inhibitor of Glutaminase in Patients with Relapsed/Refractory Leukemia. Blood. 2015;126:2566.
-
(2015)
Blood
, vol.126
, pp. 2566
-
-
Wang, E.S.F.O.1
Orford, K.W.2
Bennett, M.K.3
Flinn, I.W.4
Maris, M.B.5
Konopleva, M.Y.6
-
64
-
-
85026214749
-
Phase 1 study of CB-839, a small molecule inhibitor of glutaminase (GLS) in combination with paclitaxel (Pac) in patients (pts) with triple negative breast cancer (TNBC)
-
DeMichele AHJ, Telli ML, Munster P, McKay R, Iliopoulos O, Orford KW, Bennett MK, Mier JW, Owonikoko TK, Patel MR, Carvajal RD, Meric-Bernstam F, Infante JR. Phase 1 study of CB-839, a small molecule inhibitor of glutaminase (GLS) in combination with paclitaxel (Pac) in patients (pts) with triple negative breast cancer (TNBC). J Clin Oncol. 2015;33(15-suppl):2152.
-
(2015)
J Clin Oncol
, vol.33
, Issue.15
, pp. 2152
-
-
DeMichele, A.H.J.1
Telli, M.L.2
Munster, P.3
McKay, R.4
Iliopoulos, O.5
Orford, K.W.6
Bennett, M.K.7
Mier, J.W.8
Owonikoko, T.K.9
Patel, M.R.10
Carvajal, R.D.11
Meric-Bernstam, F.12
Infante, J.R.13
-
65
-
-
84964670673
-
Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor
-
1:CAS:528:DC%2BC28XmvFegtr8%3D 27126896 4855534
-
Krall AS, Xu S, Graeber TG, Braas D, Christofk HR. Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor. Nat Commun. 2016;7:11457.
-
(2016)
Nat Commun
, vol.7
, pp. 11457
-
-
Krall, A.S.1
Xu, S.2
Graeber, T.G.3
Braas, D.4
Christofk, H.R.5
-
66
-
-
0019216216
-
Asparagine as precursor for transmitter aspartate in corticostriatal fibres
-
1:CAS:528:DyaL3cXmtVWksLs%3D 6109000
-
Reubi JC, Toggenburger G, Cuenod M. Asparagine as precursor for transmitter aspartate in corticostriatal fibres. J Neurochem. 1980;35(4):1015-7.
-
(1980)
J Neurochem
, vol.35
, Issue.4
, pp. 1015-1017
-
-
Reubi, J.C.1
Toggenburger, G.2
Cuenod, M.3
-
67
-
-
0030267033
-
Modulation of protein structure and function by asparagine-linked glycosylation
-
8939697
-
O'Connor SE, Imperiali B. Modulation of protein structure and function by asparagine-linked glycosylation. Chem Biol. 1996;3(10):803-12.
-
(1996)
Chem Biol
, vol.3
, Issue.10
, pp. 803-812
-
-
O'Connor, S.E.1
Imperiali, B.2
-
68
-
-
33646892873
-
Asparagine-linked protein glycosylation: From eukaryotic to prokaryotic systems
-
1:CAS:528:DC%2BD28XkvVSrsL8%3D 16510493
-
Weerapana E, Imperiali B. Asparagine-linked protein glycosylation: from eukaryotic to prokaryotic systems. Glycobiology. 2006;16(6):91R-101R.
-
(2006)
Glycobiology
, vol.16
, Issue.6
, pp. 91R-101R
-
-
Weerapana, E.1
Imperiali, B.2
-
69
-
-
84922270824
-
Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion
-
1:CAS:528:DC%2BC2cXhsFyltbbL 25242145 4224619
-
Zhang J, Fan J, Venneti S, Cross JR, Takagi T, Bhinder B, Djaballah H, Kanai M, Cheng EH, Judkins AR, et al. Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion. Mol Cell. 2014;56(2):205-18.
-
(2014)
Mol Cell
, vol.56
, Issue.2
, pp. 205-218
-
-
Zhang, J.1
Fan, J.2
Venneti, S.3
Cross, J.R.4
Takagi, T.5
Bhinder, B.6
Djaballah, H.7
Kanai, M.8
Cheng, E.H.9
Judkins, A.R.10
-
70
-
-
0027193797
-
L-asparaginase kills lymphoma cells by apoptosis
-
1:CAS:528:DyaK3sXlsleksbo%3D 8485807
-
Story MD, Voehringer DW, Stephens LC, Meyn RE. L-asparaginase kills lymphoma cells by apoptosis. Cancer Chemother Pharmacol. 1993;32(2):129-33.
-
(1993)
Cancer Chemother Pharmacol
, vol.32
, Issue.2
, pp. 129-133
-
-
Story, M.D.1
Voehringer, D.W.2
Stephens, L.C.3
Meyn, R.E.4
-
71
-
-
0014767071
-
Evaluation of L-asparagine metabolism in animals and man
-
1:CAS:528:DyaE3cXksFelsrc%3D 5537323
-
Cooney DA, Capizzi RL, Handschumacher RE. Evaluation of L-asparagine metabolism in animals and man. Cancer Res. 1970;30(4):929-35.
-
(1970)
Cancer Res
, vol.30
, Issue.4
, pp. 929-935
-
-
Cooney, D.A.1
Capizzi, R.L.2
Handschumacher, R.E.3
-
72
-
-
0014424759
-
Asparagine synthetase in normal and malignant tissues: Correlation with tumor sensitivity to asparaginase
-
1:CAS:528:DyaF1cXkslGitrY%3D 4880551
-
Prager MD, Bachynsky N. Asparagine synthetase in normal and malignant tissues: correlation with tumor sensitivity to asparaginase. Arch Biochem Biophys. 1968;127(1):645-54.
-
(1968)
Arch Biochem Biophys
, vol.127
, Issue.1
, pp. 645-654
-
-
Prager, M.D.1
Bachynsky, N.2
-
73
-
-
84965111634
-
Regression of transplanted lymphomas induced in vivo by means of normal Guinea pig serum. I. Course of transplanted cancers of various kinds in mice and rats given Guinea pig serum, horse serum, or rabbit serum
-
1:CAS:528:DyaG2cXit1GmtA%3D%3D 13109110 2136344
-
Kidd JG. Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. I. Course of transplanted cancers of various kinds in mice and rats given guinea pig serum, horse serum, or rabbit serum. J Exp Med. 1953;98(6):565-82.
-
(1953)
J Exp Med
, vol.98
, Issue.6
, pp. 565-582
-
-
Kidd, J.G.1
-
74
-
-
75449142384
-
Evidence that the L-asparaginase of Guinea pig serum is responsible for its antilymphoma effects. I. Properties of the L-asparaginase of Guinea pig serum in relation to those of the antilymphoma substance
-
1:CAS:528:DyaF3sXkvVCnsbY%3D 14015821 2137570
-
Broome JD. Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. I. Properties of the L-asparaginase of guinea pig serum in relation to those of the antilymphoma substance. J Exp Med. 1963;118:99-120.
-
(1963)
J Exp Med
, vol.118
, pp. 99-120
-
-
Broome, J.D.1
-
75
-
-
0015834189
-
L-asparaginase for the treatment of cancer
-
1:STN:280:DyaE3s3lslOmtw%3D%3D 4200100
-
McCredie KB, Ho DH, Freireich EJ. L-asparaginase for the treatment of cancer. CA Cancer J Clin. 1973;23(4):220-7.
-
(1973)
CA Cancer J Clin
, vol.23
, Issue.4
, pp. 220-227
-
-
McCredie, K.B.1
Ho, D.H.2
Freireich, E.J.3
-
76
-
-
0014445065
-
Amino acid levels following L-asparagine amidohydrolase (EC.3.5.1.1) therapy
-
1:STN:280:DyaF1M7gtlyktQ%3D%3D 5763976
-
Miller HK, Salser JS, Balis ME. Amino acid levels following L-asparagine amidohydrolase (EC.3.5.1.1) therapy. Cancer Res. 1969;29(1):183-7.
-
(1969)
Cancer Res
, vol.29
, Issue.1
, pp. 183-187
-
-
Miller, H.K.1
Salser, J.S.2
Balis, M.E.3
-
77
-
-
84866763134
-
L-asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer
-
1:CAS:528:DC%2BC38XhvVOis7nE 22333033 3416969
-
Yu M, Henning R, Walker A, Kim G, Perroy A, Alessandro R, Virador V, Kohn EC. L-asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer. J Cell Mol Med. 2012;16(10):2369-78.
-
(2012)
J Cell Mol Med
, vol.16
, Issue.10
, pp. 2369-2378
-
-
Yu, M.1
Henning, R.2
Walker, A.3
Kim, G.4
Perroy, A.5
Alessandro, R.6
Virador, V.7
Kohn, E.C.8
-
78
-
-
84894411858
-
Antitumor activity of L-asparaginase from Erwinia carotovora from against different leukemic and solid tumours cell lines
-
1:CAS:528:DC%2BC2cXjsV2jsA%3D%3D 24479339
-
Abakumova O, Podobed OV, Karalkin PA, Kondakova LI, Sokolov NN. Antitumor activity of L-asparaginase from Erwinia carotovora from against different leukemic and solid tumours cell lines. Biomed Khim. 2013;59(5):498-513.
-
(2013)
Biomed Khim
, vol.59
, Issue.5
, pp. 498-513
-
-
Abakumova, O.1
Podobed, O.V.2
Karalkin, P.A.3
Kondakova, L.I.4
Sokolov, N.N.5
-
79
-
-
84900384684
-
Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors
-
1:CAS:528:DC%2BC2cXnslCrsr8%3D 24505127 4020976
-
Panosyan EH, Wang Y, Xia P, Lee WN, Pak Y, Laks DR, Lin HJ, Moore TB, Cloughesy TF, Kornblum HI, et al. Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors. Mol Cancer Res. 2014;12(5):694-702.
-
(2014)
Mol Cancer Res
, vol.12
, Issue.5
, pp. 694-702
-
-
Panosyan, E.H.1
Wang, Y.2
Xia, P.3
Lee, W.N.4
Pak, Y.5
Laks, D.R.6
Lin, H.J.7
Moore, T.B.8
Cloughesy, T.F.9
Kornblum, H.I.10
-
80
-
-
83455236523
-
Expanding targets for a metabolic therapy of cancer: L-asparaginase
-
1:CAS:528:DC%2BC38XitVeiurs%3D 21854356
-
Covini D, Tardito S, Bussolati O, Chiarelli LR, Pasquetto MV, Digilio R, Valentini G, Scotti C. Expanding targets for a metabolic therapy of cancer: L-asparaginase. Recent Pat Anticancer Drug Discov. 2012;7(1):4-13.
-
(2012)
Recent Pat Anticancer Drug Discov
, vol.7
, Issue.1
, pp. 4-13
-
-
Covini, D.1
Tardito, S.2
Bussolati, O.3
Chiarelli, L.R.4
Pasquetto, M.V.5
Digilio, R.6
Valentini, G.7
Scotti, C.8
-
81
-
-
0014960102
-
L-asparaginase in treatment of acute leukaemia and lymphosarcoma
-
1:STN:280:DyaE3c7gsV2qug%3D%3D 4904933 1699280
-
Beard ME, Crowther D, Galton DA, Guyer RJ, Fairley GH, Kay HE, Knapton PJ, Malpas JS, Scott RB. L-asparaginase in treatment of acute leukaemia and lymphosarcoma. Br Med J. 1970;1(5690):191-5.
-
(1970)
Br Med J
, vol.1
, Issue.5690
, pp. 191-195
-
-
Beard, M.E.1
Crowther, D.2
Galton, D.A.3
Guyer, R.J.4
Fairley, G.H.5
Kay, H.E.6
Knapton, P.J.7
Malpas, J.S.8
Scott, R.B.9
-
82
-
-
0017360242
-
L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia
-
1:STN:280:DyaE2s%2FovFejsw%3D%3D 264412
-
Ortega JA, Nesbit Jr ME, Donaldson MH, Hittle RE, Weiner J, Karon M, Hammond D. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia. Cancer Res. 1977;37(2):535-40.
-
(1977)
Cancer Res
, vol.37
, Issue.2
, pp. 535-540
-
-
Ortega, J.A.1
Nesbit, M.E.2
Donaldson, M.H.3
Hittle, R.E.4
Weiner, J.5
Karon, M.6
Hammond, D.7
-
83
-
-
84906856779
-
A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia
-
1:STN:280:DC%2BC2cbosFOisQ%3D%3D 25083816 4219466
-
Samuels AL, Beesley AH, Yadav BD, Papa RA, Sutton R, Anderson D, Marshall GM, Cole CH, Kees UR, Lock RB. A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia. Blood Cancer J. 2014;4:e232.
-
(2014)
Blood Cancer J
, vol.4
, pp. e232
-
-
Samuels, A.L.1
Beesley, A.H.2
Yadav, B.D.3
Papa, R.A.4
Sutton, R.5
Anderson, D.6
Marshall, G.M.7
Cole, C.H.8
Kees, U.R.9
Lock, R.B.10
-
84
-
-
68849086963
-
A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginase
-
1:CAS:528:DC%2BD1MXosVCrsrk%3D 19509471 2701869
-
Patel N, Krishnan S, Offman MN, Krol M, Moss CX, Leighton C, van Delft FW, Holland M, Liu J, Alexander S, et al. A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginase. J Clin Invest. 2009;119(7):1964-73.
-
(2009)
J Clin Invest
, vol.119
, Issue.7
, pp. 1964-1973
-
-
Patel, N.1
Krishnan, S.2
Offman, M.N.3
Krol, M.4
Moss, C.X.5
Leighton, C.6
Van Delft, F.W.7
Holland, M.8
Liu, J.9
Alexander, S.10
-
85
-
-
0037085747
-
A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: A Children's Cancer Group study
-
1:CAS:528:DC%2BD38XitF2nt7c%3D 11877270
-
Avramis VI, Sencer S, Periclou AP, Sather H, Bostrom BC, Cohen LJ, Ettinger AG, Ettinger LJ, Franklin J, Gaynon PS, et al. A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. Blood. 2002;99(6):1986-94.
-
(2002)
Blood
, vol.99
, Issue.6
, pp. 1986-1994
-
-
Avramis, V.I.1
Sencer, S.2
Periclou, A.P.3
Sather, H.4
Bostrom, B.C.5
Cohen, L.J.6
Ettinger, A.G.7
Ettinger, L.J.8
Franklin, J.9
Gaynon, P.S.10
-
86
-
-
0015056367
-
Immunological responses to L-asparaginase
-
1:CAS:528:DyaE3MXktVehsbw%3D 4101590 292030
-
Peterson RG, Handschumacher RE, Mitchell MS. Immunological responses to L-asparaginase. J Clin Invest. 1971;50(5):1080-90.
-
(1971)
J Clin Invest
, vol.50
, Issue.5
, pp. 1080-1090
-
-
Peterson, R.G.1
Handschumacher, R.E.2
Mitchell, M.S.3
-
87
-
-
0035397709
-
Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells
-
1:CAS:528:DC%2BD3MXlt1Oisr4%3D 11415466 1221958
-
Aslanian AM, Fletcher BS, Kilberg MS. Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells. Biochem J. 2001;357(Pt 1):321-8.
-
(2001)
Biochem J
, vol.357
, pp. 321-328
-
-
Aslanian, A.M.1
Fletcher, B.S.2
Kilberg, M.S.3
-
88
-
-
0014588094
-
L-asparaginase resistance in human leukemia - Asparagine synthetase
-
1:CAS:528:DyaE3cXhtV2jtw%3D%3D 4935103
-
Haskell CM, Canellos GP. l-asparaginase resistance in human leukemia - asparagine synthetase. Biochem Pharmacol. 1969;18(10):2578-80.
-
(1969)
Biochem Pharmacol
, vol.18
, Issue.10
, pp. 2578-2580
-
-
Haskell, C.M.1
Canellos, G.P.2
-
89
-
-
33845591794
-
An inhibitor of human asparagine synthetase suppresses proliferation of an L-asparaginase-resistant leukemia cell line
-
1:CAS:528:DC%2BD2sXht1CjsQ%3D%3D 17185229 3608209
-
Gutierrez JA, Pan YX, Koroniak L, Hiratake J, Kilberg MS, Richards NG. An inhibitor of human asparagine synthetase suppresses proliferation of an L-asparaginase-resistant leukemia cell line. Chem Biol. 2006;13(12):1339-47.
-
(2006)
Chem Biol
, vol.13
, Issue.12
, pp. 1339-1347
-
-
Gutierrez, J.A.1
Pan, Y.X.2
Koroniak, L.3
Hiratake, J.4
Kilberg, M.S.5
Richards, N.G.6
-
90
-
-
84952939515
-
Differential mechanisms of asparaginase resistance in B-type acute lymphoblastic leukemia and malignant natural killer cell lines
-
1:CAS:528:DC%2BC2MXosVKns7k%3D 25626693 5389037
-
Chien WW, Le Beux C, Rachinel N, Julien M, Lacroix CE, Allas S, Sahakian P, Cornut-Thibaut A, Lionnard L, Kucharczak J, et al. Differential mechanisms of asparaginase resistance in B-type acute lymphoblastic leukemia and malignant natural killer cell lines. Sci Rep. 2015;5:8068.
-
(2015)
Sci Rep
, vol.5
, pp. 8068
-
-
Chien, W.W.1
Le Beux, C.2
Rachinel, N.3
Julien, M.4
Lacroix, C.E.5
Allas, S.6
Sahakian, P.7
Cornut-Thibaut, A.8
Lionnard, L.9
Kucharczak, J.10
-
91
-
-
22544474183
-
Inhibition of glutamine synthetase triggers apoptosis in asparaginase-resistant cells
-
1:CAS:528:DC%2BD2MXmtlGrt74%3D 16037693
-
Rotoli BM, Uggeri J, Dall'Asta V, Visigalli R, Barilli A, Gatti R, Orlandini G, Gazzola GC, Bussolati O. Inhibition of glutamine synthetase triggers apoptosis in asparaginase-resistant cells. Cell Physiol Biochem. 2005;15(6):281-92.
-
(2005)
Cell Physiol Biochem
, vol.15
, Issue.6
, pp. 281-292
-
-
Rotoli, B.M.1
Uggeri, J.2
Dall'Asta, V.3
Visigalli, R.4
Barilli, A.5
Gatti, R.6
Orlandini, G.7
Gazzola, G.C.8
Bussolati, O.9
-
92
-
-
84887522014
-
Tumor microenvironment: Bone marrow-mesenchymal stem cells as key players
-
1:CAS:528:DC%2BC3sXhvFWitrzN 24183942
-
Barcellos-de-Souza P, Gori V, Bambi F, Chiarugi P. Tumor microenvironment: bone marrow-mesenchymal stem cells as key players. Biochim Biophys Acta. 2013;1836(2):321-35.
-
(2013)
Biochim Biophys Acta
, vol.1836
, Issue.2
, pp. 321-335
-
-
Barcellos-De-Souza, P.1
Gori, V.2
Bambi, F.3
Chiarugi, P.4
-
93
-
-
34147153377
-
Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase
-
1:CAS:528:DC%2BD2sXktVOit78%3D 17380207 1821067
-
Iwamoto S, Mihara K, Downing JR, Pui CH, Campana D. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J Clin Invest. 2007;117(4):1049-57.
-
(2007)
J Clin Invest
, vol.117
, Issue.4
, pp. 1049-1057
-
-
Iwamoto, S.1
Mihara, K.2
Downing, J.R.3
Pui, C.H.4
Campana, D.5
-
94
-
-
7944222582
-
Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents
-
1:CAS:528:DC%2BD2cXhtVentbzE 15491295
-
Li J, Law HK, Lau YL, Chan GC. Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents. Br J Haematol. 2004;127(3):326-34.
-
(2004)
Br J Haematol
, vol.127
, Issue.3
, pp. 326-334
-
-
Li, J.1
Law, H.K.2
Lau, Y.L.3
Chan, G.C.4
-
95
-
-
77249148314
-
Vincristine but not imatinib could suppress mesenchymal niche's support to lymphoid leukemic cells
-
1:CAS:528:DC%2BC3cXitVOmsL8%3D 19925050
-
Fung KL, Liang RH, Chan GC. Vincristine but not imatinib could suppress mesenchymal niche's support to lymphoid leukemic cells. Leuk Lymphoma. 2010;51(3):515-22.
-
(2010)
Leuk Lymphoma
, vol.51
, Issue.3
, pp. 515-522
-
-
Fung, K.L.1
Liang, R.H.2
Chan, G.C.3
-
96
-
-
78650705940
-
Purification and characterization of glutaminase-free L-asparaginase from Pectobacterium carotovorum MTCC 1428
-
1:CAS:528:DC%2BC3MXitlaisw%3D%3D 20832300
-
Kumar S, Venkata Dasu V, Pakshirajan K. Purification and characterization of glutaminase-free L-asparaginase from Pectobacterium carotovorum MTCC 1428. Bioresour Technol. 2011;102(2):2077-82.
-
(2011)
Bioresour Technol
, vol.102
, Issue.2
, pp. 2077-2082
-
-
Kumar, S.1
Venkata Dasu, V.2
Pakshirajan, K.3
-
97
-
-
79551625096
-
Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity
-
1:CAS:528:DC%2BC3MXit1Kksbw%3D 21106986
-
Offman MN, Krol M, Patel N, Krishnan S, Liu J, Saha V, Bates PA. Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity. Blood. 2011;117(5):1614-21.
-
(2011)
Blood
, vol.117
, Issue.5
, pp. 1614-1621
-
-
Offman, M.N.1
Krol, M.2
Patel, N.3
Krishnan, S.4
Liu, J.5
Saha, V.6
Bates, P.A.7
-
98
-
-
4744370294
-
Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia
-
15382279
-
Zalewska-Szewczyk B, Andrzejewski W, Bodalski J. Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2004;43(5):600-2.
-
(2004)
Pediatr Blood Cancer
, vol.43
, Issue.5
, pp. 600-602
-
-
Zalewska-Szewczyk, B.1
Andrzejewski, W.2
Bodalski, J.3
-
99
-
-
78650976352
-
L-asparaginase treatment in acute lymphoblastic leukemia: A focus on Erwinia asparaginase
-
1:CAS:528:DC%2BC3MXhs1yrsbs%3D 20824725
-
Pieters R, Hunger SP, Boos J, Rizzari C, Silverman L, Baruchel A, Goekbuget N, Schrappe M, Pui CH. L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase. Cancer. 2011;117(2):238-49.
-
(2011)
Cancer
, vol.117
, Issue.2
, pp. 238-249
-
-
Pieters, R.1
Hunger, S.P.2
Boos, J.3
Rizzari, C.4
Silverman, L.5
Baruchel, A.6
Goekbuget, N.7
Schrappe, M.8
Pui, C.H.9
-
100
-
-
80455158077
-
Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: A Children's Oncology Group Study (POG 8866)
-
1:CAS:528:DC%2BC3MXhtl2ku7nE 22042277 3557823
-
Kurtzberg J, Asselin B, Bernstein M, Buchanan GR, Pollock BH, Camitta BM. Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866). J Pediatr Hematol Oncol. 2011;33(8):610-6.
-
(2011)
J Pediatr Hematol Oncol
, vol.33
, Issue.8
, pp. 610-616
-
-
Kurtzberg, J.1
Asselin, B.2
Bernstein, M.3
Buchanan, G.R.4
Pollock, B.H.5
Camitta, B.M.6
-
101
-
-
0041520550
-
Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients
-
1:CAS:528:DC%2BD3sXlslOit78%3D 12886246
-
Wang B, Relling MV, Storm MC, Woo MH, Ribeiro R, Pui CH, Hak LJ. Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients. Leukemia. 2003;17(8):1583-8.
-
(2003)
Leukemia
, vol.17
, Issue.8
, pp. 1583-1588
-
-
Wang, B.1
Relling, M.V.2
Storm, M.C.3
Woo, M.H.4
Ribeiro, R.5
Pui, C.H.6
Hak, L.J.7
-
102
-
-
0037089437
-
Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: Results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial
-
1:CAS:528:DC%2BD38XivVyqurg%3D 11929760
-
Duval M, Suciu S, Ferster A, Rialland X, Nelken B, Lutz P, Benoit Y, Robert A, Manel AM, Vilmer E, et al. Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial. Blood. 2002;99(8):2734-9.
-
(2002)
Blood
, vol.99
, Issue.8
, pp. 2734-2739
-
-
Duval, M.1
Suciu, S.2
Ferster, A.3
Rialland, X.4
Nelken, B.5
Lutz, P.6
Benoit, Y.7
Robert, A.8
Manel, A.M.9
Vilmer, E.10
-
103
-
-
0025642988
-
Non-randomised study comparing toxicity of Escherichia coli and Erwinia asparaginase in children with leukaemia
-
1:STN:280:DyaK3M%2Fkt1Whtg%3D%3D 2233523
-
Eden OB, Shaw MP, Lilleyman JS, Richards S. Non-randomised study comparing toxicity of Escherichia coli and Erwinia asparaginase in children with leukaemia. Med Pediatr Oncol. 1990;18(6):497-502.
-
(1990)
Med Pediatr Oncol
, vol.18
, Issue.6
, pp. 497-502
-
-
Eden, O.B.1
Shaw, M.P.2
Lilleyman, J.S.3
Richards, S.4
-
104
-
-
0032613231
-
The three asparaginases. Comparative pharmacology and optimal use in childhood leukemia
-
1:CAS:528:DC%2BD3cXis1Ciurk%3D 10500842
-
Asselin BL. The three asparaginases. Comparative pharmacology and optimal use in childhood leukemia. Adv Exp Med Biol. 1999;457:621-9.
-
(1999)
Adv Exp Med Biol
, vol.457
, pp. 621-629
-
-
Asselin, B.L.1
-
105
-
-
84866242603
-
Erwinia asparaginase in pediatric acute lymphoblastic leukemia
-
1:CAS:528:DC%2BC38XhtlCrt73L 22946493
-
Salzer W, Seibel N, Smith M. Erwinia asparaginase in pediatric acute lymphoblastic leukemia. Expert Opin Biol Ther. 2012;12(10):1407-14.
-
(2012)
Expert Opin Biol Ther
, vol.12
, Issue.10
, pp. 1407-1414
-
-
Salzer, W.1
Seibel, N.2
Smith, M.3
-
106
-
-
84930732833
-
Pharmacology, immunogenicity, and efficacy of a novel pegylated recombinant Erwinia chrysanthemi-derived L-asparaginase
-
1:CAS:528:DC%2BC2cXotFGqurw%3D 24829072
-
Chien WW, Allas S, Rachinel N, Sahakian P, Julien M, Le Beux C, Lacroix CE, Abribat T, Salles G. Pharmacology, immunogenicity, and efficacy of a novel pegylated recombinant Erwinia chrysanthemi-derived L-asparaginase. Invest New Drugs. 2014;32(5):795-805.
-
(2014)
Invest New Drugs
, vol.32
, Issue.5
, pp. 795-805
-
-
Chien, W.W.1
Allas, S.2
Rachinel, N.3
Sahakian, P.4
Julien, M.5
Le Beux, C.6
Lacroix, C.E.7
Abribat, T.8
Salles, G.9
-
107
-
-
33644852813
-
Arginine: Beyond protein
-
1:CAS:528:DC%2BD28Xhs1eisbs%3D 16470022
-
Morris Jr SM. Arginine: beyond protein. Am J Clin Nutr. 2006;83(2):508S-12S.
-
(2006)
Am J Clin Nutr
, vol.83
, Issue.2
, pp. 12S-508S
-
-
Morris, S.M.1
-
108
-
-
0036921474
-
Arginine: Clinical potential of a semi-essential amino acid
-
12495375
-
Appleton J. Arginine: Clinical potential of a semi-essential amino acid. Altern Med Rev. 2002;7(6):512-22.
-
(2002)
Altern Med Rev
, vol.7
, Issue.6
, pp. 512-522
-
-
Appleton, J.1
-
109
-
-
0028268676
-
A structural role for arginine in proteins: Multiple hydrogen bonds to backbone carbonyl oxygens
-
1:CAS:528:DyaK2cXmslCnurk%3D 8003972 2142871
-
Borders Jr CL, Broadwater JA, Bekeny PA, Salmon JE, Lee AS, Eldridge AM, Pett VB. A structural role for arginine in proteins: multiple hydrogen bonds to backbone carbonyl oxygens. Protein Sci. 1994;3(4):541-8.
-
(1994)
Protein Sci
, vol.3
, Issue.4
, pp. 541-548
-
-
Borders, C.L.1
Broadwater, J.A.2
Bekeny, P.A.3
Salmon, J.E.4
Lee, A.S.5
Eldridge, A.M.6
Pett, V.B.7
-
110
-
-
4744355192
-
Enzymes of arginine metabolism
-
1:CAS:528:DC%2BD2cXosVOjsrw%3D 15465778 discussion 65S-67S
-
Morris Jr SM. Enzymes of arginine metabolism. J Nutr. 2004;134(10 Suppl):2743S-47S. discussion 65S-67S.
-
(2004)
J Nutr
, vol.134
, Issue.10
, pp. 47S-2743S
-
-
Morris, S.M.1
-
111
-
-
84947922181
-
Arginine deprivation affects glioblastoma cell adhesion, invasiveness and actin cytoskeleton organization by impairment of beta-actin arginylation
-
1:CAS:528:DC%2BC2cXhvVOlurzJ 25362567
-
Pavlyk I, Rzhepetskyy Y, Jagielski AK, Drozak J, Wasik A, Pereverzieva G, Olchowik M, Kunz-Schugart LA, Stasyk O, Redowicz MJ. Arginine deprivation affects glioblastoma cell adhesion, invasiveness and actin cytoskeleton organization by impairment of beta-actin arginylation. Amino Acids. 2015;47(1):199-212.
-
(2015)
Amino Acids
, vol.47
, Issue.1
, pp. 199-212
-
-
Pavlyk, I.1
Rzhepetskyy, Y.2
Jagielski, A.K.3
Drozak, J.4
Wasik, A.5
Pereverzieva, G.6
Olchowik, M.7
Kunz-Schugart, L.A.8
Stasyk, O.9
Redowicz, M.J.10
-
112
-
-
0001657454
-
Effect of arginine on tumor growth in rats
-
1:CAS:528:DyaG2cXmsFehsQ%3D%3D 13150333
-
Levy HM, Montañez G, Feaver ER, Murphy EA, Dunn MS. Effect of arginine on tumor growth in rats. Cancer Res. 1954;14(3):198-200.
-
(1954)
Cancer Res
, vol.14
, Issue.3
, pp. 198-200
-
-
Levy, H.M.1
Montañez, G.2
Feaver, E.R.3
Murphy, E.A.4
Dunn, M.S.5
-
113
-
-
84964282787
-
Arginine dependence of tumor cells: Targeting a chink in cancer's armor
-
Patil MD, Bhaumik J, Babykutty S, Banerjee UC, Fukumura D. Arginine dependence of tumor cells: targeting a chink in cancer's armor. Oncogene. 2016;35(38):4957-72.
-
(2016)
Oncogene
, vol.35
, Issue.38
, pp. 4957-4972
-
-
Patil, M.D.1
Bhaumik, J.2
Babykutty, S.3
Banerjee, U.C.4
Fukumura, D.5
-
114
-
-
0033997424
-
Expression and localization of inducible nitric oxide synthase in human non-pregnant and early pregnant endometrium
-
1:CAS:528:DC%2BD3cXitVCgu7k%3D 10694278
-
Yoshiki N, Kubota T, Aso T. Expression and localization of inducible nitric oxide synthase in human non-pregnant and early pregnant endometrium. Mol Hum Reprod. 2000;6(3):283-7.
-
(2000)
Mol Hum Reprod
, vol.6
, Issue.3
, pp. 283-287
-
-
Yoshiki, N.1
Kubota, T.2
Aso, T.3
-
115
-
-
70350780368
-
Mammalian polyamine metabolism and function
-
1:CAS:528:DC%2BD1MXhtFSgtrfN 19603518 2753421
-
Pegg AE. Mammalian polyamine metabolism and function. IUBMB Life. 2009;61(9):880-94.
-
(2009)
IUBMB Life
, vol.61
, Issue.9
, pp. 880-894
-
-
Pegg, A.E.1
-
116
-
-
33846416533
-
Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: Involvement of mammalian target of rapamycin/eIF4E pathway
-
1:CAS:528:DC%2BD2sXisFSlug%3D%3D 17210710
-
Pervin S, Singh R, Hernandez E, Wu G, Chaudhuri G. Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway. Cancer Res. 2007;67(1):289-99.
-
(2007)
Cancer Res
, vol.67
, Issue.1
, pp. 289-299
-
-
Pervin, S.1
Singh, R.2
Hernandez, E.3
Wu, G.4
Chaudhuri, G.5
-
117
-
-
84878220531
-
Nitric oxide and cancer: A review
-
23718886
-
Choudhari SK, Chaudhary M, Bagde S, Gadbail AR, Joshi V. Nitric oxide and cancer: a review. World J Surg Oncol. 2013;11:118.
-
(2013)
World J Surg Oncol
, vol.11
, pp. 118
-
-
Choudhari, S.K.1
Chaudhary, M.2
Bagde, S.3
Gadbail, A.R.4
Joshi, V.5
-
118
-
-
0036207944
-
Influence of nitric oxide on the generation and repair of oxidative DNA damage in mammalian cells
-
1:CAS:528:DC%2BD38Xis1KntLc%3D 11895862
-
Phoa N, Epe B. Influence of nitric oxide on the generation and repair of oxidative DNA damage in mammalian cells. Carcinogenesis. 2002;23(3):469-75.
-
(2002)
Carcinogenesis
, vol.23
, Issue.3
, pp. 469-475
-
-
Phoa, N.1
Epe, B.2
-
119
-
-
0014323475
-
Amine synthesis in rapidly growing tissues: Ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors
-
1:CAS:528:DyaF1cXltVCltL8%3D 4299947 224936
-
Russell D, Snyder SH. Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors. Proc Natl Acad Sci U S A. 1968;60(4):1420-7.
-
(1968)
Proc Natl Acad Sci U S A
, vol.60
, Issue.4
, pp. 1420-1427
-
-
Russell, D.1
Snyder, S.H.2
-
120
-
-
0022298558
-
Urinary polyamines as a tumor marker
-
1:STN:280:DyaL28%2Fltlentg%3D%3D 4064039
-
Kubota S, Okada M, Yoshimoto M, Murata N, Yamasaki Z, Wada T, Imahori K, Ohsawa N, Takaku F. Urinary polyamines as a tumor marker. Cancer Detect Prev. 1985;8(1-2):189-92.
-
(1985)
Cancer Detect Prev
, vol.8
, Issue.1-2
, pp. 189-192
-
-
Kubota, S.1
Okada, M.2
Yoshimoto, M.3
Murata, N.4
Yamasaki, Z.5
Wada, T.6
Imahori, K.7
Ohsawa, N.8
Takaku, F.9
-
121
-
-
0018913827
-
Elevated contents of spermidine and spermine in the erythrocytes of cancer patients
-
1:STN:280:DyaL3c%2FovFOitg%3D%3D 7350997
-
Uehara N, Shirakawa S, Uchino H, Saeki Y. Elevated contents of spermidine and spermine in the erythrocytes of cancer patients. Cancer. 1980;45(1):108-11.
-
(1980)
Cancer
, vol.45
, Issue.1
, pp. 108-111
-
-
Uehara, N.1
Shirakawa, S.2
Uchino, H.3
Saeki, Y.4
-
122
-
-
35348848363
-
Polyamines and nonmelanoma skin cancer
-
1:CAS:528:DC%2BD2sXhtF2mtL7P 17234230
-
Gilmour SK. Polyamines and nonmelanoma skin cancer. Toxicol Appl Pharmacol. 2007;224(3):249-56.
-
(2007)
Toxicol Appl Pharmacol
, vol.224
, Issue.3
, pp. 249-256
-
-
Gilmour, S.K.1
-
123
-
-
0034665334
-
Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice
-
1:CAS:528:DC%2BD3cXntVamtbY%3D 11016639
-
Gupta S, Ahmad N, Marengo SR, MacLennan GT, Greenberg NM, Mukhtar H. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice. Cancer Res. 2000;60(18):5125-33.
-
(2000)
Cancer Res
, vol.60
, Issue.18
, pp. 5125-5133
-
-
Gupta, S.1
Ahmad, N.2
Marengo, S.R.3
MacLennan, G.T.4
Greenberg, N.M.5
Mukhtar, H.6
-
124
-
-
0029832374
-
Prognostic influence on survival of increased ornithine decarboxylase activity in human breast cancer
-
1:STN:280:DyaK1M%2FjsFahtQ%3D%3D 9816147
-
Manni A, Mauger D, Gimotty P, Badger B. Prognostic influence on survival of increased ornithine decarboxylase activity in human breast cancer. Clin Cancer Res. 1996;2(11):1901-6.
-
(1996)
Clin Cancer Res
, vol.2
, Issue.11
, pp. 1901-1906
-
-
Manni, A.1
Mauger, D.2
Gimotty, P.3
Badger, B.4
-
125
-
-
84880515627
-
Polyamines and cancer: Implications for chemotherapy and chemoprevention
-
23432971 4027058
-
Nowotarski SL, Woster PM, Casero Jr RA. Polyamines and cancer: implications for chemotherapy and chemoprevention. Expert Rev Mol Med. 2013;15:e3.
-
(2013)
Expert Rev Mol Med
, vol.15
, pp. e3
-
-
Nowotarski, S.L.1
Woster, P.M.2
Casero, R.A.3
-
126
-
-
0023897010
-
Polyamine levels and gastrin receptors in colon cancers
-
1:CAS:528:DyaL1cXkvFSmsbk%3D 3389934 1493553
-
Upp Jr JR, Saydjari R, Townsend Jr CM, Singh P, Barranco SC, Thompson JC. Polyamine levels and gastrin receptors in colon cancers. Ann Surg. 1988;207(6):662-9.
-
(1988)
Ann Surg
, vol.207
, Issue.6
, pp. 662-669
-
-
Upp, J.R.1
Saydjari, R.2
Townsend, C.M.3
Singh, P.4
Barranco, S.C.5
Thompson, J.C.6
-
127
-
-
0001068795
-
The Effect of Arginase on the Retardation of Tumour Growth
-
1:CAS:528:DyaF2MXks1KjtLc%3D 14316215 2071380
-
Bach SJ, Swaine D. The Effect of Arginase on the Retardation of Tumour Growth. Br J Cancer. 1965;19:379-86.
-
(1965)
Br J Cancer
, vol.19
, pp. 379-386
-
-
Bach, S.J.1
Swaine, D.2
-
128
-
-
85047696245
-
The effects of arginine deficiency on lymphoma cells
-
1:CAS:528:DyaE2MXisVeq 4528778 2009188
-
Storr JM, Burton AF. The effects of arginine deficiency on lymphoma cells. Br J Cancer. 1974;30(1):50-9.
-
(1974)
Br J Cancer
, vol.30
, Issue.1
, pp. 50-59
-
-
Storr, J.M.1
Burton, A.F.2
-
129
-
-
19344365089
-
Remission of hepatocellular carcinoma with arginine depletion induced by systemic release of endogenous hepatic arginase due to transhepatic arterial embolisation, augmented by high-dose insulin: Arginase as a potential drug candidate for hepatocellular carcinoma
-
1:CAS:528:DC%2BD2MXks1akt78%3D 15911102
-
Cheng PN, Leung YC, Lo WH, Tsui SM, Lam KC. Remission of hepatocellular carcinoma with arginine depletion induced by systemic release of endogenous hepatic arginase due to transhepatic arterial embolisation, augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma. Cancer Lett. 2005;224(1):67-80.
-
(2005)
Cancer Lett
, vol.224
, Issue.1
, pp. 67-80
-
-
Cheng, P.N.1
Leung, Y.C.2
Lo, W.H.3
Tsui, S.M.4
Lam, K.C.5
-
130
-
-
33747181970
-
Pegylated arginine deiminase: A novel anticancer enzyme agent
-
1:CAS:528:DC%2BD28XmvVKiur0%3D 16787144 3086545
-
Feun L, Savaraj N. Pegylated arginine deiminase: a novel anticancer enzyme agent. Expert Opin Investig Drugs. 2006;15(7):815-22.
-
(2006)
Expert Opin Investig Drugs
, vol.15
, Issue.7
, pp. 815-822
-
-
Feun, L.1
Savaraj, N.2
-
131
-
-
77952316981
-
Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma
-
1:CAS:528:DC%2BC3cXpsFSgtrw%3D
-
Glazer ES, Piccirillo M, Albino V, Di Giacomo R, Palaia R, Mastro AA, Beneduce G, Castello G, De Rosa V, Petrillo A, et al. Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28(13):2220-6.
-
(2010)
J Clin Oncol off J Am Soc Clin Oncol
, vol.28
, Issue.13
, pp. 2220-2226
-
-
Glazer, E.S.1
Piccirillo, M.2
Albino, V.3
Di Giacomo, R.4
Palaia, R.5
Mastro, A.A.6
Beneduce, G.7
Castello, G.8
De Rosa, V.9
Petrillo, A.10
-
132
-
-
58349098150
-
Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis
-
1:CAS:528:DC%2BD1MXltFSguw%3D%3D 19147587 2629384
-
Kim RH, Coates JM, Bowles TL, McNerney GP, Sutcliffe J, Jung JU, Gandour-Edwards R, Chuang FY, Bold RJ, Kung HJ. Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. Cancer Res. 2009;69(2):700-8.
-
(2009)
Cancer Res
, vol.69
, Issue.2
, pp. 700-708
-
-
Kim, R.H.1
Coates, J.M.2
Bowles, T.L.3
McNerney, G.P.4
Sutcliffe, J.5
Jung, J.U.6
Gandour-Edwards, R.7
Chuang, F.Y.8
Bold, R.J.9
Kung, H.J.10
-
133
-
-
85010312669
-
A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas
-
1:CAS:528:DC%2BC28Xhs1yqsLzP 27735949 5133958
-
Bean GR, Kremer JC, Prudner BC, Schenone AD, Yao JC, Schultze MB, Chen DY, Tanas MR, Adkins DR, Bomalaski J, et al. A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas. Cell Death Dis. 2016;7(10):e2406.
-
(2016)
Cell Death Dis
, vol.7
, Issue.10
, pp. e2406
-
-
Bean, G.R.1
Kremer, J.C.2
Prudner, B.C.3
Schenone, A.D.4
Yao, J.C.5
Schultze, M.B.6
Chen, D.Y.7
Tanas, M.R.8
Adkins, D.R.9
Bomalaski, J.10
-
134
-
-
84943793263
-
Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo
-
1:CAS:528:DC%2BC2MXhvFWls7bL 25774632 4623118
-
Fiedler T, Strauss M, Hering S, Redanz U, William D, Rosche Y, Classen CF, Kreikemeyer B, Linnebacher M, Maletzki C. Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo. Cancer Biol Ther. 2015;16(7):1047-55.
-
(2015)
Cancer Biol Ther
, vol.16
, Issue.7
, pp. 1047-1055
-
-
Fiedler, T.1
Strauss, M.2
Hering, S.3
Redanz, U.4
William, D.5
Rosche, Y.6
Classen, C.F.7
Kreikemeyer, B.8
Linnebacher, M.9
Maletzki, C.10
-
135
-
-
84907387232
-
Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-kappaB signaling
-
25240403 4189535
-
Liu J, Ma J, Wu Z, Li W, Zhang D, Han L, Wang F, Reindl KM, Wu E, Ma Q. Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-kappaB signaling. BMC Cancer. 2014;14:686.
-
(2014)
BMC Cancer
, vol.14
, pp. 686
-
-
Liu, J.1
Ma, J.2
Wu, Z.3
Li, W.4
Zhang, D.5
Han, L.6
Wang, F.7
Reindl, K.M.8
Wu, E.9
Ma, Q.10
-
136
-
-
33846429217
-
Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion
-
1:CAS:528:DC%2BD2sXisFSksQ%3D%3D 17210712
-
Cheng PN, Lam TL, Lam WM, Tsui SM, Cheng AW, Lo WH, Leung YC. Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion. Cancer Res. 2007;67(1):309-17.
-
(2007)
Cancer Res
, vol.67
, Issue.1
, pp. 309-317
-
-
Cheng, P.N.1
Lam, T.L.2
Lam, W.M.3
Tsui, S.M.4
Cheng, A.W.5
Lo, W.H.6
Leung, Y.C.7
-
137
-
-
84933556272
-
Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo
-
1:CAS:528:DC%2BC2MXhtlehsLrP 25896651
-
Miraki-Moud F, Ghazaly E, Ariza-McNaughton L, Hodby KA, Clear A, Anjos-Afonso F, Liapis K, Grantham M, Sohrabi F, Cavenagh J, et al. Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo. Blood. 2015;125(26):4060-8.
-
(2015)
Blood
, vol.125
, Issue.26
, pp. 4060-4068
-
-
Miraki-Moud, F.1
Ghazaly, E.2
Ariza-McNaughton, L.3
Hodby, K.A.4
Clear, A.5
Anjos-Afonso, F.6
Liapis, K.7
Grantham, M.8
Sohrabi, F.9
Cavenagh, J.10
-
138
-
-
84911473209
-
The role of arginine and the modified arginine deiminase enzyme ADI-PEG 20 in cancer therapy with special emphasis on Phase I/II clinical trials
-
1:CAS:528:DC%2BC2cXhsleitLrL 24965808
-
Synakiewicz A, Stachowicz-Stencel T, Adamkiewicz-Drozynska E. The role of arginine and the modified arginine deiminase enzyme ADI-PEG 20 in cancer therapy with special emphasis on Phase I/II clinical trials. Expert Opin Investig Drugs. 2014;23(11):1517-29.
-
(2014)
Expert Opin Investig Drugs
, vol.23
, Issue.11
, pp. 1517-1529
-
-
Synakiewicz, A.1
Stachowicz-Stencel, T.2
Adamkiewicz-Drozynska, E.3
-
139
-
-
85017339834
-
Arginine Deprivation with Pegylated Arginine Deiminase in Patients with Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical Trial
-
27584578
-
Szlosarek PW, Steele JP, Nolan L, Gilligan D, Taylor P, Spicer J, Lind M, Mitra S, Shamash J, Phillips MM, et al. Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical Trial. JAMA Oncol. 2017;3(1):58-66.
-
(2017)
JAMA Oncol
, vol.3
, Issue.1
, pp. 58-66
-
-
Szlosarek, P.W.1
Steele, J.P.2
Nolan, L.3
Gilligan, D.4
Taylor, P.5
Spicer, J.6
Lind, M.7
Mitra, S.8
Shamash, J.9
Phillips, M.M.10
-
140
-
-
32944469353
-
Pegylated arginine deiminase treatment of patients with metastatic melanoma: Results from phase i and II studies
-
1:CAS:528:DC%2BD2MXht1Wrsr3L
-
Ascierto PA, Scala S, Castello G, Daponte A, Simeone E, Ottaiano A, Beneduce G, De Rosa V, Izzo F, Melucci MT, et al. Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23(30):7660-8.
-
(2005)
J Clin Oncol off J Am Soc Clin Oncol
, vol.23
, Issue.30
, pp. 7660-7668
-
-
Ascierto, P.A.1
Scala, S.2
Castello, G.3
Daponte, A.4
Simeone, E.5
Ottaiano, A.6
Beneduce, G.7
De Rosa, V.8
Izzo, F.9
Melucci, M.T.10
-
141
-
-
84879550695
-
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma
-
1:CAS:528:DC%2BC3sXjsleisLg%3D 22864522
-
Ott PA, Carvajal RD, Pandit-Taskar N, Jungbluth AA, Hoffman EW, Wu BW, Bomalaski JS, Venhaus R, Pan L, Old LJ, et al. Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma. Invest New Drugs. 2013;31(2):425-34.
-
(2013)
Invest New Drugs
, vol.31
, Issue.2
, pp. 425-434
-
-
Ott, P.A.1
Carvajal, R.D.2
Pandit-Taskar, N.3
Jungbluth, A.A.4
Hoffman, E.W.5
Wu, B.W.6
Bomalaski, J.S.7
Venhaus, R.8
Pan, L.9
Old, L.J.10
-
142
-
-
84941962550
-
Phase i Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors
-
1:CAS:528:DC%2BC2MXps1aktbo%3D 25739672 4452427
-
Tomlinson BK, Thomson JA, Bomalaski JS, Diaz M, Akande T, Mahaffey N, Li T, Dutia MP, Kelly K, Gong IY, et al. Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors. Clin Cancer Res. 2015;21(11):2480-6.
-
(2015)
Clin Cancer Res
, vol.21
, Issue.11
, pp. 2480-2486
-
-
Tomlinson, B.K.1
Thomson, J.A.2
Bomalaski, J.S.3
Diaz, M.4
Akande, T.5
Mahaffey, N.6
Li, T.7
Dutia, M.P.8
Kelly, K.9
Gong, I.Y.10
-
143
-
-
85020391329
-
Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients with Argininosuccinate Synthetase 1-Deficient Thoracic Cancers
-
Beddowes E, Spicer J, Chan PY, Khadeir R, Corbacho JG, Repana D, Steele JP, Schmid P, Szyszko T, Cook G, et al. Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1-Deficient Thoracic Cancers. J Clin Oncol Off J Am Soc Clin Oncol. 2017;35(16):1778-85.
-
(2017)
J Clin Oncol off J Am Soc Clin Oncol
, vol.35
, Issue.16
, pp. 1778-1785
-
-
Beddowes, E.1
Spicer, J.2
Chan, P.Y.3
Khadeir, R.4
Corbacho, J.G.5
Repana, D.6
Steele, J.P.7
Schmid, P.8
Szyszko, T.9
Cook, G.10
-
144
-
-
84861154164
-
Activation of Ras/PI3K/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells
-
1:CAS:528:DC%2BC38XmvF2ntbg%3D 22461507 3433038
-
Tsai WB, Aiba I, Long Y, Lin HK, Feun L, Savaraj N, Kuo MT. Activation of Ras/PI3K/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells. Cancer Res. 2012;72(10):2622-33.
-
(2012)
Cancer Res
, vol.72
, Issue.10
, pp. 2622-2633
-
-
Tsai, W.B.1
Aiba, I.2
Long, Y.3
Lin, H.K.4
Feun, L.5
Savaraj, N.6
Kuo, M.T.7
-
145
-
-
84887483618
-
Arginine deiminase resistance in melanoma cells is associated with metabolic reprogramming, glucose dependence, and glutamine addiction
-
1:CAS:528:DC%2BC3sXhslarsrfI 23979920
-
Long Y, Tsai WB, Wangpaichitr M, Tsukamoto T, Savaraj N, Feun LG, Kuo MT. Arginine deiminase resistance in melanoma cells is associated with metabolic reprogramming, glucose dependence, and glutamine addiction. Mol Cancer Ther. 2013;12(11):2581-90.
-
(2013)
Mol Cancer Ther
, vol.12
, Issue.11
, pp. 2581-2590
-
-
Long, Y.1
Tsai, W.B.2
Wangpaichitr, M.3
Tsukamoto, T.4
Savaraj, N.5
Feun, L.G.6
Kuo, M.T.7
-
146
-
-
84953440017
-
Selective Intracellular Delivery of Recombinant Arginine Deiminase (ADI) Using pH-Sensitive Cell Penetrating Peptides to Overcome ADI Resistance in Hypoxic Breast Cancer Cells
-
1:CAS:528:DC%2BC2MXhvFKjtbzK 26642391
-
Yeh TH, Chen YR, Chen SY, Shen WC, Ann DK, Zaro JL, Shen LJ. Selective Intracellular Delivery of Recombinant Arginine Deiminase (ADI) Using pH-Sensitive Cell Penetrating Peptides To Overcome ADI Resistance in Hypoxic Breast Cancer Cells. Mol Pharm. 2016;13(1):262-71.
-
(2016)
Mol Pharm
, vol.13
, Issue.1
, pp. 262-271
-
-
Yeh, T.H.1
Chen, Y.R.2
Chen, S.Y.3
Shen, W.C.4
Ann, D.K.5
Zaro, J.L.6
Shen, L.J.7
-
147
-
-
85010445349
-
Arginine Deprivation Inhibits the Warburg Effect and Upregulates Glutamine Anaplerosis and Serine Biosynthesis in ASS1-Deficient Cancers
-
1:CAS:528:DC%2BC2sXhs1Gqt74%3D 28122247
-
Kremer JC, Prudner BC, Lange SE, Bean GR, Schultze MB, Brashears CB, Radyk MD, Redlich N, Tzeng SC, Kami K, et al. Arginine Deprivation Inhibits the Warburg Effect and Upregulates Glutamine Anaplerosis and Serine Biosynthesis in ASS1-Deficient Cancers. Cell Rep. 2017;18(4):991-1004.
-
(2017)
Cell Rep
, vol.18
, Issue.4
, pp. 991-1004
-
-
Kremer, J.C.1
Prudner, B.C.2
Lange, S.E.3
Bean, G.R.4
Schultze, M.B.5
Brashears, C.B.6
Radyk, M.D.7
Redlich, N.8
Tzeng, S.C.9
Kami, K.10
-
148
-
-
85018992572
-
Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts
-
28464918 5414232
-
Lam SK, Li YY, Xu S, Leung LL UKP, Zheng YF, Cheng PN, Ho JC. Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts. Respir Res. 2017;18(1):80.
-
(2017)
Respir Res
, vol.18
, Issue.1
, pp. 80
-
-
Lam, S.K.1
Li, Y.Y.2
Xu, S.3
Leung, L.L.U.K.P.4
Zheng, Y.F.5
Cheng, P.N.6
Ho, J.C.7
-
149
-
-
84989931404
-
Inhibition of the Polyamine Synthesis Pathway Is Synthetically Lethal with Loss of Argininosuccinate Synthase 1
-
1:CAS:528:DC%2BC28Xht1CksrzN 27452468 4978703
-
Locke M, Ghazaly E, Freitas MO, Mitsinga M, Lattanzio L, Lo Nigro C, Nagano A, Wang J, Chelala C, Szlosarek P, et al. Inhibition of the Polyamine Synthesis Pathway Is Synthetically Lethal with Loss of Argininosuccinate Synthase 1. Cell Rep. 2016;16(6):1604-13.
-
(2016)
Cell Rep
, vol.16
, Issue.6
, pp. 1604-1613
-
-
Locke, M.1
Ghazaly, E.2
Freitas, M.O.3
Mitsinga, M.4
Lattanzio, L.5
Lo Nigro, C.6
Nagano, A.7
Wang, J.8
Chelala, C.9
Szlosarek, P.10
-
150
-
-
84975475311
-
BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma
-
26771234 4951241
-
Li YY, Wu C, Chen SM, Shah SS, Wangpaichitr M, Feun LG, Kuo MT, Suarez M, Prince J, Savaraj N. BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma. Oncotarget. 2016;7(14):17665-80.
-
(2016)
Oncotarget
, vol.7
, Issue.14
, pp. 17665-17680
-
-
Li, Y.Y.1
Wu, C.2
Chen, S.M.3
Shah, S.S.4
Wangpaichitr, M.5
Feun, L.G.6
Kuo, M.T.7
Suarez, M.8
Prince, J.9
Savaraj, N.10
-
151
-
-
77950003784
-
Replacing Mn(2+) with Co(2+) in human arginase i enhances cytotoxicity toward l-arginine auxotrophic cancer cell lines
-
1:CAS:528:DC%2BC3cXovVagsw%3D%3D 20050660 2842482
-
Stone EM, Glazer ES, Chantranupong L, Cherukuri P, Breece RM, Tierney DL, Curley SA, Iverson BL, Georgiou G. Replacing Mn(2+) with Co(2+) in human arginase i enhances cytotoxicity toward l-arginine auxotrophic cancer cell lines. ACS Chem Biol. 2010;5(3):333-42.
-
(2010)
ACS Chem Biol
, vol.5
, Issue.3
, pp. 333-342
-
-
Stone, E.M.1
Glazer, E.S.2
Chantranupong, L.3
Cherukuri, P.4
Breece, R.M.5
Tierney, D.L.6
Curley, S.A.7
Iverson, B.L.8
Georgiou, G.9
-
152
-
-
84856008075
-
Recombinant human arginase toxicity in mice is reduced by citrulline supplementation
-
22348173 3281408
-
Mauldin JP, Zeinali I, Kleypas K, Woo JH, Blackwood RS, Jo CH, Stone EM, Georgiou G, Frankel AE. Recombinant human arginase toxicity in mice is reduced by citrulline supplementation. Transl Oncol. 2012;5(1):26-31.
-
(2012)
Transl Oncol
, vol.5
, Issue.1
, pp. 26-31
-
-
Mauldin, J.P.1
Zeinali, I.2
Kleypas, K.3
Woo, J.H.4
Blackwood, R.S.5
Jo, C.H.6
Stone, E.M.7
Georgiou, G.8
Frankel, A.E.9
-
153
-
-
84893377315
-
Vincristine could partly suppress stromal support to T-ALL blasts during pegylated arginase i treatment
-
23574711 3655039
-
Kwong-Lam F, Chi-Fung CG. Vincristine could partly suppress stromal support to T-ALL blasts during pegylated arginase I treatment. Exp Hematol Oncol. 2013;2(1):11.
-
(2013)
Exp Hematol Oncol
, vol.2
, Issue.1
, pp. 11
-
-
Kwong-Lam, F.1
Chi-Fung, C.G.2
-
154
-
-
84927547048
-
Arginine dependence of acute myeloid leukemia blast proliferation: A novel therapeutic target
-
1:CAS:528:DC%2BC2MXmsl2htLo%3D 25710880 4416943
-
Mussai F, Egan S, Higginbotham-Jones J, Perry T, Beggs A, Odintsova E, Loke J, Pratt G, KP U, Lo A, et al. Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target. Blood. 2015;125(15):2386-96.
-
(2015)
Blood
, vol.125
, Issue.15
, pp. 2386-2396
-
-
Mussai, F.1
Egan, S.2
Higginbotham-Jones, J.3
Perry, T.4
Beggs, A.5
Odintsova, E.6
Loke, J.7
Pratt, G.8
Kp, U.9
Lo, A.10
-
155
-
-
77954661588
-
Pegylated arginase I: A potential therapeutic approach in T-ALL
-
1:CAS:528:DC%2BC3cXovVWltLo%3D 20407034 2892956
-
Hernandez CP, Morrow K, Lopez-Barcons LA, Zabaleta J, Sierra R, Velasco C, Cole J, Rodriguez PC. Pegylated arginase I: a potential therapeutic approach in T-ALL. Blood. 2010;115(25):5214-21.
-
(2010)
Blood
, vol.115
, Issue.25
, pp. 5214-5221
-
-
Hernandez, C.P.1
Morrow, K.2
Lopez-Barcons, L.A.3
Zabaleta, J.4
Sierra, R.5
Velasco, C.6
Cole, J.7
Rodriguez, P.C.8
-
156
-
-
84878739789
-
An Engineered Arginase FC Protein Inhibits Tumor Growth in Vitro and in Vivo
-
23737831 3662114
-
Li L, Wang Y, Chen J, Cheng B, Hu J, Zhou Y, Gao X, Gao L, Mei X, Sun M, et al. An Engineered Arginase FC Protein Inhibits Tumor Growth In Vitro and In Vivo. Evid Based Complement Alternat Med. 2013;2013:423129.
-
(2013)
Evid Based Complement Alternat Med
, vol.2013
, pp. 423129
-
-
Li, L.1
Wang, Y.2
Chen, J.3
Cheng, B.4
Hu, J.5
Zhou, Y.6
Gao, X.7
Gao, L.8
Mei, X.9
Sun, M.10
-
157
-
-
1642450643
-
Expression of human arginine decarboxylase, the biosynthetic enzyme for agmatine
-
1:CAS:528:DC%2BD2cXltV2isQ%3D%3D 14738999 3118518
-
Zhu MY, Iyo A, Piletz JE, Regunathan S. Expression of human arginine decarboxylase, the biosynthetic enzyme for agmatine. Biochim Biophys Acta. 2004;1670(2):156-64.
-
(2004)
Biochim Biophys Acta
, vol.1670
, Issue.2
, pp. 156-164
-
-
Zhu, M.Y.1
Iyo, A.2
Piletz, J.E.3
Regunathan, S.4
-
158
-
-
0037463235
-
Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures
-
1:CAS:528:DC%2BD3sXht1Gltbg%3D 12592378 2377179
-
Philip R, Campbell E, Wheatley DN. Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures. Br J Cancer. 2003;88(4):613-23.
-
(2003)
Br J Cancer
, vol.88
, Issue.4
, pp. 613-623
-
-
Philip, R.1
Campbell, E.2
Wheatley, D.N.3
-
160
-
-
85009820190
-
Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer
-
1:CAS:528:DC%2BC2sXht1ChsL4%3D 28099841 5260616
-
Momcilovic M, Bailey ST, Lee JT, Fishbein MC, Magyar C, Braas D, Graeber T, Jackson NJ, Czernin J, Emberley E, et al. Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer. Cell Rep. 2017;18(3):601-10.
-
(2017)
Cell Rep
, vol.18
, Issue.3
, pp. 601-610
-
-
Momcilovic, M.1
Bailey, S.T.2
Lee, J.T.3
Fishbein, M.C.4
Magyar, C.5
Braas, D.6
Graeber, T.7
Jackson, N.J.8
Czernin, J.9
Emberley, E.10
-
161
-
-
85026230339
-
Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells
-
28415782 5482623
-
Thompson RM, Dytfeld D, Reyes L, Robinson RM, Smith B, Manevich Y, Jakubowiak A, Komarnicki M, Przybylowicz-Chalecka A, Szczepaniak T, et al. Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells. Oncotarget. 2017;8(22):35863-76.
-
(2017)
Oncotarget
, vol.8
, Issue.22
, pp. 35863-35876
-
-
Thompson, R.M.1
Dytfeld, D.2
Reyes, L.3
Robinson, R.M.4
Smith, B.5
Manevich, Y.6
Jakubowiak, A.7
Komarnicki, M.8
Przybylowicz-Chalecka, A.9
Szczepaniak, T.10
-
162
-
-
78049515429
-
Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model
-
1:CAS:528:DC%2BC3cXht1GqtLjJ 20473919 2946425
-
Shelton LM, Huysentruyt LC, Seyfried TN. Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model. Int J Cancer. 2010;127(10):2478-85.
-
(2010)
Int J Cancer
, vol.127
, Issue.10
, pp. 2478-2485
-
-
Shelton, L.M.1
Huysentruyt, L.C.2
Seyfried, T.N.3
-
163
-
-
84920990454
-
Mechanism by which a recently discovered allosteric inhibitor blocks glutamine metabolism in transformed cells
-
1:CAS:528:DC%2BC2MXltVak 25548170
-
Stalnecker CA, Ulrich SM, Li Y, Ramachandran S, McBrayer MK, DeBerardinis RJ, Cerione RA, Erickson JW. Mechanism by which a recently discovered allosteric inhibitor blocks glutamine metabolism in transformed cells. Proc Natl Acad Sci U S A. 2015;112(2):394-9.
-
(2015)
Proc Natl Acad Sci U S A
, vol.112
, Issue.2
, pp. 394-399
-
-
Stalnecker, C.A.1
Ulrich, S.M.2
Li, Y.3
Ramachandran, S.4
McBrayer, M.K.5
DeBerardinis, R.J.6
Cerione, R.A.7
Erickson, J.W.8
-
164
-
-
84856458783
-
Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase
-
1:CAS:528:DC%2BC38XhtVGhu7Y%3D 22134507
-
Kelly MP, Jungbluth AA, Wu BW, Bomalaski J, Old LJ, Ritter G. Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase. Br J Cancer. 2012;106(2):324-32.
-
(2012)
Br J Cancer
, vol.106
, Issue.2
, pp. 324-332
-
-
Kelly, M.P.1
Jungbluth, A.A.2
Wu, B.W.3
Bomalaski, J.4
Old, L.J.5
Ritter, G.6
-
165
-
-
84872184647
-
Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma
-
1:STN:280:DC%2BC3szgsVansw%3D%3D 23328665 3563985
-
Syed N, Langer J, Janczar K, Singh P, Lo Nigro C, Lattanzio L, Coley HM, Hatzimichael E, Bomalaski J, Szlosarek P, et al. Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma. Cell Death Dis. 2013;4:e458.
-
(2013)
Cell Death Dis
, vol.4
, pp. e458
-
-
Syed, N.1
Langer, J.2
Janczar, K.3
Singh, P.4
Lo Nigro, C.5
Lattanzio, L.6
Coley, H.M.7
Hatzimichael, E.8
Bomalaski, J.9
Szlosarek, P.10
-
166
-
-
51949087021
-
Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase
-
1:CAS:528:DC%2BD1cXhtFKgsr3O 18661517 4294549
-
Bowles TL, Kim R, Galante J, Parsons CM, Virudachalam S, Kung HJ, Bold RJ. Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase. Int J Cancer. 2008;123(8):1950-5.
-
(2008)
Int J Cancer
, vol.123
, Issue.8
, pp. 1950-1955
-
-
Bowles, T.L.1
Kim, R.2
Galante, J.3
Parsons, C.M.4
Virudachalam, S.5
Kung, H.J.6
Bold, R.J.7
-
167
-
-
84965191759
-
Pegylated arginine deiminase synergistically increases the cytotoxicity of gemcitabine in human pancreatic cancer
-
25499121 4279680
-
Daylami R, Muilenburg DJ, Virudachalam S, Bold RJ. Pegylated arginine deiminase synergistically increases the cytotoxicity of gemcitabine in human pancreatic cancer. J Exp Clin Cancer Res. 2014;33:102.
-
(2014)
J Exp Clin Cancer Res
, vol.33
, pp. 102
-
-
Daylami, R.1
Muilenburg, D.J.2
Virudachalam, S.3
Bold, R.J.4
-
168
-
-
84907587227
-
Arginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage, and chromatin autophagy
-
1:CAS:528:DC%2BC2cXhtlGntLzN 25122679 4191793
-
Changou CA, Chen YR, Xing L, Yen Y, Chuang FY, Cheng RH, Bold RJ, Ann DK, Kung HJ. Arginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage, and chromatin autophagy. Proc Natl Acad Sci U S A. 2014;111(39):14147-52.
-
(2014)
Proc Natl Acad Sci U S A
, vol.111
, Issue.39
, pp. 14147-14152
-
-
Changou, C.A.1
Chen, Y.R.2
Xing, L.3
Yen, Y.4
Chuang, F.Y.5
Cheng, R.H.6
Bold, R.J.7
Ann, D.K.8
Kung, H.J.9
-
169
-
-
85006434615
-
Argininosuccinate Synthetase 1 Loss in Invasive Bladder Cancer Regulates Survival through General Control Nonderepressible 2 Kinase-Mediated Eukaryotic Initiation Factor 2alpha Activity and Is Targetable by Pegylated Arginine Deiminase
-
Sahu D, Gupta S, Hau AM, Nakashima K, Leivo MZ, Searles SC, Elson P, Bomalaski JS, Casteel DE, Boss GR, et al. Argininosuccinate Synthetase 1 Loss in Invasive Bladder Cancer Regulates Survival through General Control Nonderepressible 2 Kinase-Mediated Eukaryotic Initiation Factor 2alpha Activity and Is Targetable by Pegylated Arginine Deiminase. Am J Pathol. 2016. doi: 10.1016/j.ajpath.2016.09.004.
-
(2016)
Am J Pathol
-
-
Sahu, D.1
Gupta, S.2
Hau, A.M.3
Nakashima, K.4
Leivo, M.Z.5
Searles, S.C.6
Elson, P.7
Bomalaski, J.S.8
De, C.9
Boss, G.R.10
-
170
-
-
84893856177
-
Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging
-
1:CAS:528:DC%2BC2cXhvVSmt70%3D 24285724
-
Allen MD, Luong P, Hudson C, Leyton J, Delage B, Ghazaly E, Cutts R, Yuan M, Syed N, Lo Nigro C, et al. Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging. Cancer Res. 2014;74(3):896-907.
-
(2014)
Cancer Res
, vol.74
, Issue.3
, pp. 896-907
-
-
Allen, M.D.1
Luong, P.2
Hudson, C.3
Leyton, J.4
Delage, B.5
Ghazaly, E.6
Cutts, R.7
Yuan, M.8
Syed, N.9
Lo Nigro, C.10
-
171
-
-
84904421955
-
Arginine starvation impairs mitochondrial respiratory function in ASS1-deficient breast cancer cells
-
24692592 4229039
-
Qiu F, Chen YR, Liu X, Chu CY, Shen LJ, Xu J, Gaur S, Forman HJ, Zhang H, Zheng S, et al. Arginine starvation impairs mitochondrial respiratory function in ASS1-deficient breast cancer cells. Sci Signal. 2014;7(319):ra31.
-
(2014)
Sci Signal
, vol.7
, Issue.319
, pp. ra31
-
-
Qiu, F.1
Chen, Y.R.2
Liu, X.3
Chu, C.Y.4
Shen, L.J.5
Xu, J.6
Gaur, S.7
Forman, H.J.8
Zhang, H.9
Zheng, S.10
-
172
-
-
79957919927
-
Bioengineered human arginase i with enhanced activity and stability controls hepatocellular and pancreatic carcinoma xenografts
-
21633669 3104694
-
Glazer ES, Stone EM, Zhu C, Massey KL, Hamir AN, Curley SA. Bioengineered human arginase I with enhanced activity and stability controls hepatocellular and pancreatic carcinoma xenografts. Transl Oncol. 2011;4(3):138-46.
-
(2011)
Transl Oncol
, vol.4
, Issue.3
, pp. 138-146
-
-
Glazer, E.S.1
Stone, E.M.2
Zhu, C.3
Massey, K.L.4
Hamir, A.N.5
Curley, S.A.6
-
173
-
-
84875220307
-
Anti-leukemic mechanisms of pegylated arginase i in acute lymphoblastic T-cell leukemia
-
1:CAS:528:DC%2BC3sXjslWntrs%3D 22926702
-
Morrow K, Hernandez CP, Raber P, Del Valle L, Wilk AM, Majumdar S, Wyczechowska D, Reiss K, Rodriguez PC. Anti-leukemic mechanisms of pegylated arginase I in acute lymphoblastic T-cell leukemia. Leukemia. 2013;27(3):569-77.
-
(2013)
Leukemia
, vol.27
, Issue.3
, pp. 569-577
-
-
Morrow, K.1
Hernandez, C.P.2
Raber, P.3
Del Valle, L.4
Wilk, A.M.5
Majumdar, S.6
Wyczechowska, D.7
Reiss, K.8
Rodriguez, P.C.9
-
174
-
-
84925490226
-
Human recombinant arginase i (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells
-
1:CAS:528:DC%2BC2MXhtVCrsLc%3D 25567351
-
Khoury O, Ghazale N, Stone E, El-Sibai M, Frankel AE, Abi-Habib RJ. Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells. J Neurooncol. 2015;122(1):75-85.
-
(2015)
J Neurooncol
, vol.122
, Issue.1
, pp. 75-85
-
-
Khoury, O.1
Ghazale, N.2
Stone, E.3
El-Sibai, M.4
Frankel, A.E.5
Abi-Habib, R.J.6
-
175
-
-
79952598775
-
Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis
-
1:CAS:528:DC%2BC3MXltFaktrs%3D 21029397
-
Lam TL, Wong GK, Chow HY, Chong HC, Chow TL, Kwok SY, Cheng PN, Wheatley DN, Lo WH, Leung YC. Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis. Pigment Cell Melanoma Res. 2011;24(2):366-76.
-
(2011)
Pigment Cell Melanoma Res
, vol.24
, Issue.2
, pp. 366-376
-
-
Lam, T.L.1
Wong, G.K.2
Chow, H.Y.3
Chong, H.C.4
Chow, T.L.5
Kwok, S.Y.6
Cheng, P.N.7
Wheatley, D.N.8
Lo, W.H.9
Leung, Y.C.10
-
176
-
-
84862187475
-
Deprivation of arginine by recombinant human arginase in prostate cancer cells
-
1:CAS:528:DC%2BC38XhtFCqsLvL 22546217 3403903
-
Hsueh EC, Knebel SM, Lo WH, Leung YC, Cheng PN, Hsueh CT. Deprivation of arginine by recombinant human arginase in prostate cancer cells. J Hematol Oncol. 2012;5:17.
-
(2012)
J Hematol Oncol
, vol.5
, pp. 17
-
-
Hsueh, E.C.1
Knebel, S.M.2
Lo, W.H.3
Leung, Y.C.4
Cheng, P.N.5
Hsueh, C.T.6
|